0000766704false2023Q2December 31P1Yhttp://www.welltower.com/20230630#LeaseRightOfUseAssethttp://www.welltower.com/20230630#LeaseRightOfUseAssethttp://www.welltower.com/20230630#LeaseRightOfUseAssethttp://www.welltower.com/20230630#LeaseRightOfUseAssethttp://www.welltower.com/20230630#ReceivablesAndOtherAssetshttp://www.welltower.com/20230630#ReceivablesAndOtherAssetshttp://fasb.org/us-gaap/2023#RealEstateHeldforsalehttp://fasb.org/us-gaap/2023#RealEstateHeldforsalehttp://www.welltower.com/20230630#LeaseLiabilityhttp://www.welltower.com/20230630#LeaseLiabilityhttp://www.welltower.com/20230630#LeaseLiabilityhttp://www.welltower.com/20230630#LeaseLiability0.0104808P3Y00007667042023-01-012023-06-300000766704us-gaap:CommonStockMember2023-01-012023-06-300000766704well:GuaranteeNotesDue20284800Member2023-01-012023-06-300000766704well:GuaranteeNotesDue20344500Member2023-01-012023-06-3000007667042023-07-28xbrli:shares00007667042023-06-30iso4217:USD00007667042022-12-310000766704us-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:ManagementServiceMember2022-01-012022-06-3000007667042023-04-012023-06-3000007667042022-04-012022-06-3000007667042022-01-012022-06-300000766704well:InterestRevenueMember2023-04-012023-06-300000766704well:InterestRevenueMember2022-04-012022-06-300000766704well:InterestRevenueMember2023-01-012023-06-300000766704well:InterestRevenueMember2022-01-012022-06-300000766704us-gaap:ProductAndServiceOtherMember2023-04-012023-06-300000766704us-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000766704us-gaap:ProductAndServiceOtherMember2023-01-012023-06-300000766704us-gaap:ProductAndServiceOtherMember2022-01-012022-06-30iso4217:USDxbrli:shares0000766704us-gaap:CommonStockMember2022-12-310000766704us-gaap:AdditionalPaidInCapitalMember2022-12-310000766704us-gaap:TreasuryStockCommonMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-12-310000766704well:AccumulatedDistributionsMember2022-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000766704us-gaap:NoncontrollingInterestMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-01-012023-03-310000766704us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100007667042023-01-012023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000766704well:AccumulatedDistributionsMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-03-310000766704us-gaap:TreasuryStockCommonMember2023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-03-310000766704well:AccumulatedDistributionsMember2023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000766704us-gaap:NoncontrollingInterestMember2023-03-3100007667042023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-04-012023-06-300000766704us-gaap:NoncontrollingInterestMember2023-04-012023-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300000766704us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300000766704us-gaap:CommonStockMember2023-04-012023-06-300000766704us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000766704well:AccumulatedDistributionsMember2023-04-012023-06-300000766704us-gaap:CommonStockMember2023-06-300000766704us-gaap:AdditionalPaidInCapitalMember2023-06-300000766704us-gaap:TreasuryStockCommonMember2023-06-300000766704us-gaap:RetainedEarningsUnappropriatedMember2023-06-300000766704well:AccumulatedDistributionsMember2023-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000766704us-gaap:NoncontrollingInterestMember2023-06-300000766704us-gaap:CommonStockMember2021-12-310000766704us-gaap:AdditionalPaidInCapitalMember2021-12-310000766704us-gaap:TreasuryStockCommonMember2021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2021-12-310000766704well:AccumulatedDistributionsMember2021-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000766704us-gaap:NoncontrollingInterestMember2021-12-3100007667042021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-01-012022-03-310000766704us-gaap:NoncontrollingInterestMember2022-01-012022-03-3100007667042022-01-012022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-01-012022-03-310000766704us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000766704well:AccumulatedDistributionsMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-03-310000766704us-gaap:TreasuryStockCommonMember2022-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-03-310000766704well:AccumulatedDistributionsMember2022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000766704us-gaap:NoncontrollingInterestMember2022-03-3100007667042022-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-04-012022-06-300000766704us-gaap:NoncontrollingInterestMember2022-04-012022-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300000766704us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300000766704us-gaap:CommonStockMember2022-04-012022-06-300000766704us-gaap:TreasuryStockCommonMember2022-04-012022-06-300000766704well:AccumulatedDistributionsMember2022-04-012022-06-300000766704us-gaap:CommonStockMember2022-06-300000766704us-gaap:AdditionalPaidInCapitalMember2022-06-300000766704us-gaap:TreasuryStockCommonMember2022-06-300000766704us-gaap:RetainedEarningsUnappropriatedMember2022-06-300000766704well:AccumulatedDistributionsMember2022-06-300000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300000766704us-gaap:NoncontrollingInterestMember2022-06-3000007667042022-06-300000766704well:WelltowerOPIncMember2023-01-012023-06-30xbrli:pure0000766704well:WelltowerOPIncMember2023-06-300000766704well:WelltowerOPIncMemberwell:OtherInvestorsMember2023-06-300000766704well:COVID19Memberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704well:COVID19Memberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704well:COVID19Memberwell:SeniorHousingOperatingMember2022-04-012022-06-300000766704well:COVID19Memberwell:SeniorHousingOperatingMember2022-01-012022-06-300000766704well:SeniorHousingOperatingMember2023-06-300000766704well:TripleNetMember2023-06-300000766704well:OutpatientMedicalMember2023-06-300000766704well:SeniorHousingOperatingMember2022-06-300000766704well:TripleNetMember2022-06-300000766704well:OutpatientMedicalMember2022-06-300000766704well:SeniorHousingOperatingMember2023-01-012023-06-300000766704well:TripleNetMember2023-01-012023-06-300000766704well:OutpatientMedicalMember2023-01-012023-06-300000766704well:SeniorHousingOperatingMember2022-01-012022-06-300000766704well:TripleNetMember2022-01-012022-06-300000766704well:OutpatientMedicalMember2022-01-012022-06-300000766704well:HolidayRetirementMember2022-04-01well:property00007667042022-04-012022-04-010000766704us-gaap:OtherIncomeMember2022-04-012022-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2023-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2022-12-310000766704us-gaap:AboveMarketLeasesMember2023-06-300000766704us-gaap:AboveMarketLeasesMember2022-12-310000766704well:LeaseCommissionsMember2023-06-300000766704well:LeaseCommissionsMember2022-12-310000766704us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2023-04-012023-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-04-012022-06-300000766704us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2022-01-012022-06-300000766704well:PublicSectorPensionInvestmentBoardMember2023-04-012023-06-300000766704well:PublicSectorPensionInvestmentBoardMember2023-04-012023-06-300000766704well:PublicSectorPensionInvestmentBoardUKPortfolioMember2023-04-012023-06-300000766704well:UKPortfolioJointVenture1Member2023-06-300000766704well:UKPortfolioJointVenture2Member2023-06-300000766704well:PublicSectorPensionInvestmentBoardUKPortfolioMember2023-04-012023-06-300000766704well:UKPortfolioJointVenture1Member2023-04-012023-06-300000766704well:PublicSectorPensionInvestmentBoardUKPortfolioMember2023-06-300000766704us-gaap:SubsequentEventMemberwell:PublicSectorPensionInvestmentBoardUSPortfolioMember2023-07-012023-07-310000766704well:USPortfolioJointVentureMember2023-06-300000766704well:USPortfolioJointVentureMemberwell:ReveraMember2023-06-300000766704us-gaap:SubsequentEventMember2023-07-012023-07-310000766704us-gaap:SubsequentEventMemberwell:PublicSectorPensionInvestmentBoardUSPortfolioMember2023-07-012023-07-31well:project0000766704us-gaap:SubsequentEventMemberwell:PublicSectorPensionInvestmentBoardUSPortfolioMember2023-07-310000766704well:PublicSectorPensionInvestmentBoardUSPortfolioMember2023-04-012023-06-300000766704well:OakmontManagementGroupMember2023-06-300000766704well:CanadianPortfolioJointVentureMember2023-06-300000766704well:CanadianPortfolioJointVentureMemberwell:ReveraMember2023-06-300000766704srt:ScenarioForecastMemberwell:PublicSectorPensionInvestmentBoardCanadianPortfolioMember2023-01-012023-12-310000766704well:PublicSectorPensionInvestmentBoardCanadianPortfolioMembersrt:ScenarioForecastMember2023-01-012023-12-310000766704well:GenesisHealthCareOperatingRelationshipMember2021-03-012021-03-310000766704well:GenesisHealthCareOperatingRelationshipMember2021-03-310000766704well:GenesisHealthCareOperatingRelationshipMember2023-03-310000766704well:JointVentureWithAuroraHealthNetworkPeaceCapitalMember2023-05-012023-05-010000766704well:JointVentureWithAuroraHealthNetworkPeaceCapitalMember2023-05-0100007667042023-05-012023-05-010000766704srt:MinimumMember2023-01-012023-06-300000766704srt:MaximumMember2023-01-012023-06-300000766704us-gaap:CostOfSalesMember2023-01-012023-06-300000766704us-gaap:CostOfSalesMember2022-01-012022-06-300000766704us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-06-300000766704us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMember2023-06-300000766704us-gaap:OperatingSegmentsMember2022-12-310000766704us-gaap:CorporateNonSegmentMember2022-12-310000766704us-gaap:CorporateNonSegmentMember2023-06-300000766704well:OperatingSegmentsAndCorporateNonSegmentMember2023-06-300000766704well:OperatingSegmentsAndCorporateNonSegmentMember2022-12-310000766704us-gaap:MortgageReceivablesMember2023-06-300000766704us-gaap:MortgageReceivablesMember2022-12-310000766704well:OtherRealEstateLoansReceivablesMember2023-06-300000766704well:OtherRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:RealEstateLoanMember2023-06-300000766704us-gaap:RealEstateLoanMember2022-12-310000766704well:DeterioratedLoansMember2023-06-30well:loan0000766704well:CollectiveLoanPool1Member2023-06-300000766704well:CollectiveLoanPool2Member2023-06-300000766704well:CollectiveLoanPool3Member2023-06-300000766704well:CollectiveLoanPool4Member2023-06-300000766704well:CollectiveLoanPool5Member2023-06-300000766704well:CollectiveLoanPool6Member2023-06-300000766704us-gaap:RealEstateLoanMember2023-06-300000766704well:SeniorsHousingOperatingMembersrt:MinimumMember2023-06-300000766704well:SeniorsHousingOperatingMembersrt:MaximumMember2023-06-300000766704well:SeniorsHousingOperatingMember2023-06-300000766704well:SeniorsHousingOperatingMember2022-12-310000766704well:TripleNetMembersrt:MinimumMember2023-06-300000766704srt:MaximumMemberwell:TripleNetMember2023-06-300000766704well:TripleNetMember2023-06-300000766704well:TripleNetMember2022-12-310000766704well:OutpatientMedicalMembersrt:MinimumMember2023-06-300000766704well:OutpatientMedicalMembersrt:MaximumMember2023-06-300000766704well:OutpatientMedicalMember2023-06-300000766704well:OutpatientMedicalMember2022-12-310000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-06-30well:properties0000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-01-012023-06-300000766704well:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:SunriseSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:SunriseSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:CogirManagementCorporationMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:CogirManagementCorporationMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:HCOneGroupMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:HCOneGroupMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:RemainingPortfolioMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:RemainingPortfolioMemberwell:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-06-300000766704well:NetOperatingingIncomeMemberus-gaap:CreditConcentrationRiskMember2023-01-012023-06-300000766704well:HCOneGroupMember2023-06-30iso4217:GBPwell:bank0000766704us-gaap:RevolvingCreditFacilityMember2023-06-300000766704well:TermCreditFacilityMember2023-06-300000766704well:TermCreditFacilityCADDenominatedMember2023-06-30iso4217:CAD0000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDue2026Member2023-06-300000766704well:CreditFacilityTrancheDue2025Memberus-gaap:RevolvingCreditFacilityMember2023-06-30well:Term0000766704us-gaap:RevolvingCreditFacilityMember2023-01-012023-06-300000766704well:AccordionfeaturememberMemberus-gaap:RevolvingCreditFacilityMember2023-06-300000766704well:AccordionfeaturememberMemberwell:TermCreditFacilityCADDenominatedMember2023-06-300000766704us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-06-300000766704srt:MaximumMemberus-gaap:CommercialPaperMember2023-01-012023-06-300000766704us-gaap:CommercialPaperMember2023-06-300000766704us-gaap:UnsecuredDebtMember2023-06-300000766704us-gaap:SecuredDebtMember2023-06-300000766704us-gaap:UnsecuredDebtMembersrt:MinimumMember2023-06-300000766704us-gaap:UnsecuredDebtMembersrt:MaximumMember2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A295SeniorUnsecuredNotesDue2023Member2023-06-300000766704us-gaap:SecuredDebtMembersrt:MinimumMember2023-06-300000766704us-gaap:SecuredDebtMembersrt:MaximumMember2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-06-30well:term0000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMemberwell:UnsecuredTermCreditFacilityMaturesJuly192023Member2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:UkDebtDue2028Member2023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A450SeniorUnsecuredNotesDue2034Member2023-06-300000766704us-gaap:UnsecuredDebtMember2022-12-310000766704us-gaap:UnsecuredDebtMember2021-12-310000766704us-gaap:UnsecuredDebtMember2023-01-012023-06-300000766704us-gaap:UnsecuredDebtMember2022-01-012022-06-300000766704us-gaap:UnsecuredDebtMember2022-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-05-310000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-05-012023-05-310000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-04-012023-06-300000766704us-gaap:UnsecuredDebtMemberwell:A2750SeniorUnsecuredNotesDue2028Member2023-06-30well:day0000766704us-gaap:SecuredDebtMember2022-12-310000766704us-gaap:SecuredDebtMember2021-12-310000766704us-gaap:SecuredDebtMember2023-01-012023-06-300000766704us-gaap:SecuredDebtMember2022-01-012022-06-300000766704us-gaap:SecuredDebtMember2022-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2022-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2023-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2022-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2023-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2022-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2023-01-012023-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:CAD2022-01-012022-12-310000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2023-01-012023-06-300000766704us-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMembercurrency:GBP2022-01-012022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMembercurrency:USD2023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMembercurrency:USD2022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMembercurrency:USD2023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMembercurrency:USD2022-12-310000766704us-gaap:NondesignatedMembercurrency:USD2023-06-300000766704us-gaap:NondesignatedMembercurrency:USD2022-12-310000766704currency:CADus-gaap:NondesignatedMember2023-06-300000766704currency:CADus-gaap:NondesignatedMember2022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-04-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2022-04-012022-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-06-300000766704us-gaap:NondesignatedMember2023-04-012023-06-300000766704us-gaap:NondesignatedMember2022-04-012022-06-300000766704us-gaap:NondesignatedMember2023-01-012023-06-300000766704us-gaap:NondesignatedMember2022-01-012022-06-300000766704us-gaap:WarrantMember2023-04-012023-06-300000766704us-gaap:WarrantMember2022-04-012022-06-300000766704us-gaap:WarrantMember2023-01-012023-06-300000766704us-gaap:WarrantMember2022-01-012022-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2023-04-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2022-04-012022-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2023-01-012023-06-300000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherComprehensiveIncomeMember2022-01-012022-06-30well:obligation0000766704well:CapitalImprovementsMember2023-06-300000766704well:AtTheMarketProgramMember2023-05-310000766704well:AtTheMarketProgramMember2023-06-300000766704us-gaap:SubsequentEventMemberwell:AtTheMarketProgramMember2023-07-012023-07-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300000766704us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-06-300000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000766704us-gaap:EmployeeStockOptionMember2022-01-012022-06-300000766704us-gaap:EmployeeStockOptionMember2023-01-012023-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MortgagesMember2023-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MortgagesMember2023-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MortgagesMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MortgagesMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-06-300000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-06-300000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:FairValueInputsLevel1Member2023-06-300000766704us-gaap:FairValueInputsLevel2Member2023-06-300000766704us-gaap:FairValueInputsLevel3Member2023-06-300000766704us-gaap:WarrantMember2022-12-310000766704us-gaap:WarrantMember2021-12-310000766704us-gaap:WarrantMember2023-01-012023-06-300000766704us-gaap:WarrantMember2022-01-012022-06-300000766704us-gaap:WarrantMember2023-06-300000766704us-gaap:WarrantMember2022-06-300000766704well:TerminalCapitalizationRateMember2023-06-300000766704well:TerminalCapitalizationRateMember2022-06-30well:segment0000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMemberus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMember2023-04-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-04-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMemberwell:InterestRevenueMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:SeniorHousingOperatingMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ProductAndServiceOtherMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:OutpatientMedicalMember2023-04-012023-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2023-04-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMemberus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:OutpatientMedicalMember2022-04-012022-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2022-04-012022-06-300000766704us-gaap:CorporateNonSegmentMember2022-04-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2022-04-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-04-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2022-04-012022-06-300000766704us-gaap:CorporateNonSegmentMemberwell:InterestRevenueMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:SeniorHousingOperatingMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:OutpatientMedicalMember2022-04-012022-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2022-04-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMemberus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMember2023-01-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMemberwell:InterestRevenueMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:SeniorHousingOperatingMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:OutpatientMedicalMember2023-01-012023-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMemberus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:OutpatientMedicalMember2022-01-012022-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2022-01-012022-06-300000766704us-gaap:CorporateNonSegmentMember2022-01-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:SeniorHousingOperatingMember2022-01-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-01-012022-06-300000766704well:InterestRevenueMemberus-gaap:OperatingSegmentsMemberwell:OutpatientMedicalMember2022-01-012022-06-300000766704us-gaap:CorporateNonSegmentMemberwell:InterestRevenueMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:SeniorHousingOperatingMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-06-300000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:OutpatientMedicalMember2022-01-012022-06-300000766704us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-06-300000766704country:US2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:US2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:US2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:US2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:GB2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:GB2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:GB2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:GB2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:CA2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:CA2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:CA2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:CA2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:USus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:USus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:USus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:USus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:GBus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:GBus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:GBus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:GBus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:CAus-gaap:ManagementServiceMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704country:CAus-gaap:ManagementServiceMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704country:CAus-gaap:ManagementServiceMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704country:CAus-gaap:ManagementServiceMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:CAus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-04-012022-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-06-300000766704country:US2023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:AssetsTotalMember2023-01-012023-06-300000766704country:US2022-12-310000766704us-gaap:GeographicConcentrationRiskMembercountry:USus-gaap:AssetsTotalMember2022-01-012022-12-310000766704country:GB2023-06-300000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:AssetsTotalMember2023-01-012023-06-300000766704country:GB2022-12-310000766704us-gaap:GeographicConcentrationRiskMembercountry:GBus-gaap:AssetsTotalMember2022-01-012022-12-310000766704country:CA2023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:CA2023-01-012023-06-300000766704country:CA2022-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMembercountry:CA2022-01-012022-12-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2023-01-012023-06-300000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:AssetsTotalMember2022-01-012022-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-06-300000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
   
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2023
or
   
 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                      
Commission file number: 1-8923
WELLTOWER INC.
 
(Exact name of registrant as specified in its charter
Delaware
34-1096634
(State or other jurisdiction
of Incorporation)
(IRS Employer
Identification No.)
4500 Dorr StreetToledo,Ohio43615
(Address of principal executive office)(Zip Code)
(419) -247-2800
(Registrant’s telephone number, including area code)  
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, $1.00 par value per shareWELLNew York Stock Exchange
Guarantee of 4.800% Notes due 2028 issued by Welltower OP LLCWELL/28New York Stock Exchange
Guarantee of 4.500% Notes due 2034 issued by Welltower OP LLCWELL/34New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ  No  ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ  No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 þ
 Accelerated filer
¨
 Non-accelerated filer
¨
 Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No  þ
As of July 28, 2023, Welltower Inc. had 518,729,078 shares of common stock outstanding.





TABLE OF CONTENTS
 
 
PART I. FINANCIAL INFORMATIONPage
  
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets
  
Consolidated Statements of Comprehensive Income
  
Consolidated Statements of Equity
  
Consolidated Statements of Cash Flows
  
Notes to Unaudited Consolidated Financial Statements
  
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
  
Item 3. Quantitative and Qualitative Disclosures About Market Risk
  
Item 4. Controls and Procedures
  
PART II. OTHER INFORMATION 
  
Item 1. Legal Proceedings
  
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
  
Item 5. Other Information
  
Item 6. Exhibits
  
Signatures



PART I. FINANCIAL INFORMATION

CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
June 30, 2023 (Unaudited)December 31, 2022 (Note)
Assets:  
  
Real estate investments:  
  
Real property owned:  
Land and land improvements  $4,262,745 $4,249,834 
Buildings and improvements  34,127,012 33,651,336 
Acquired lease intangibles  1,950,349 1,945,458 
Real property held for sale, net of accumulated depreciation  404,071 133,058 
Construction in progress  1,108,773 1,021,080 
Less accumulated depreciation and amortization  (8,599,622)(8,075,733)
Net real property owned  33,253,328 32,925,033 
Right of use assets, net322,316 323,942 
Real estate loans receivable, net of credit allowance  965,509 890,844 
Net real estate investments  34,541,153 34,139,819 
Other assets:  
Investments in unconsolidated entities  1,650,133 1,499,790 
Goodwill  68,321 68,321 
Cash and cash equivalents  2,203,788 631,681 
Restricted cash  95,281 90,611 
Straight-line rent receivable389,381 322,173 
Receivables and other assets  1,116,078 1,140,838 
Total other assets  5,522,982 3,753,414 
Total assets  
$40,064,135 $37,893,233 
Liabilities and equity  
Liabilities:  
Unsecured credit facility and commercial paper$ $ 
Senior unsecured notes  13,530,788 12,437,273 
Secured debt  2,460,349 2,110,815 
Lease liabilities348,770 415,824 
Accrued expenses and other liabilities  1,531,114 1,535,325 
Total liabilities  
17,871,021 16,499,237 
Redeemable noncontrolling interests  
369,191 384,443 
Equity:  
Common stock  509,805 491,919 
Capital in excess of par value  28,085,297 26,742,750 
Treasury stock  (112,032)(111,001)
Cumulative net income  8,933,663 8,804,950 
Cumulative dividends  (16,116,698)(15,514,097)
Accumulated other comprehensive income (loss)  (95,594)(119,707)
Total Welltower Inc. stockholders’ equity  21,204,441 20,294,814 
Noncontrolling interests  619,482 714,739 
Total equity  
21,823,923 21,009,553 
Total liabilities and equity  
$40,064,135 $37,893,233 
Note: The consolidated balance sheet at December 31, 2022 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data) 
Three Months EndedSix Months Ended
June 30,June 30,
 2023202220232022
Revenues:  
Resident fees and services$1,159,449  $1,009,999 $2,291,134 $2,004,334 
Rental income  383,439 361,411 767,498 717,801 
Interest income38,710 37,140 75,115 76,134 
Other income83,880 63,986 92,460 69,971 
Total revenues1,665,478 1,472,536 3,226,207 2,868,240 
Expenses:
Property operating expenses958,672 854,083 1,916,425 1,707,752 
Depreciation and amortization341,945 310,295 681,057 614,383 
Interest expense152,337 127,750 296,740 249,446 
General and administrative expenses44,287 36,554 88,658 74,260 
Loss (gain) on derivatives and financial instruments, net1,280 (1,407)2,210 1,171 
Loss (gain) on extinguishment of debt, net1 603 6 591 
Provision for loan losses, net2,456 165 3,233 (639)
Impairment of assets1,086  13,715  
Other expenses11,069 35,166 33,814 61,235 
Total expenses1,513,133 1,363,209 3,035,858 2,708,199 
Income (loss) from continuing operations before income taxes and other items152,345 109,327 190,349 160,041 
Income tax (expense) benefit(3,503)(3,065)(6,548)(8,078)
Income (loss) from unconsolidated entities(40,332)(7,058)(47,403)(9,942)
Gain (loss) on real estate dispositions, net(2,168)(3,532)(1,421)19,402 
Income (loss) from continuing operations106,342 95,672 134,977 161,423 
Net income (loss)106,342 95,672 134,977 161,423 
Less: Net income (loss) attributable to noncontrolling interests(1)
3,302 5,888 6,264 9,714 
Net income (loss) attributable to common stockholders$103,040 $89,784 $128,713 $151,709 
Weighted average number of common shares outstanding:
Basic499,023 454,327 495,561 450,865 
Diluted501,970 457,082 498,305 453,455 
Earnings per share:
Basic:
Income (loss) from continuing operations$0.21 $0.21 $0.27 $0.36 
Net income (loss) attributable to common stockholders$0.21 $0.20 $0.26 $0.34 
Diluted:
Income (loss) from continuing operations$0.21 $0.21 $0.27 $0.36 
Net income (loss) attributable to common stockholders(2)
$0.20 $0.20 $0.26 $0.33 
Dividends declared and paid per common share$0.61 $0.61 $1.22 $1.22 
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units.

4


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands) 
 Three Months EndedSix Months Ended
June 30,June 30,
 2023202220232022
Net income (loss)$106,342 $95,672 $134,977 $161,423 
Other comprehensive income (loss):
Foreign currency translation gain (loss)119,519 (306,723)200,284 (373,671)
Derivative and financial instruments designated as hedges gain (loss)(85,884)284,081 (155,622)336,021 
Total other comprehensive income (loss)33,635 (22,642)44,662 (37,650)
Total comprehensive income (loss)139,977 73,030 179,639 123,773 
Less: Total comprehensive income (loss) attributable
to noncontrolling interests(1)
8,286 (10,031)14,127 (4,057)
Total comprehensive income (loss) attributable to common stockholders$131,691 $83,061 $165,512 $127,830 
(1) Includes amounts attributable to redeemable noncontrolling interests.

5


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended June 30, 2023
Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2023$491,919 $26,742,750 $(111,001)$8,804,950 $(15,514,097)$(119,707)$714,739 $21,009,553 
Comprehensive income:
Net income (loss)   25,673   2,688 28,361 
Other comprehensive income (loss)    8,148 3,023 11,171 
Total comprehensive income       39,532 
Net change in noncontrolling interests (8,304)    29,648 21,344 
Adjustment to members' interest from change in ownership in Welltower OP (6,139)    6,139  
Redemption of OP Units and DownREIT Units272 17,515    (432)17,355 
Amounts related to stock incentive plans, net of forfeitures134 9,330 (1,924)    7,540 
Net proceeds from issuance of common stock5,603 404,862      410,465 
Dividends paid:
Common stock dividends    (301,829)  (301,829)
Balances at March 31, 2023$497,928 $27,160,014 $(112,925)$8,830,623 $(15,815,926)$(111,559)$755,805 $21,203,960 
Comprehensive income:
Net income (loss)103,040 3,505 106,545 
Other comprehensive income (loss)28,651 4,410 33,061 
Total comprehensive income139,606 
Net change in noncontrolling interests8,579 (12,686)(149,013)(153,120)
Adjustment to members' interest from change in ownership in Welltower OP(4,794)4,794  
Redemption of OP Units and DownREIT Units1 18 (19) 
Amounts related to stock incentive plans, net of forfeitures43 11,088 893 12,024 
Net proceeds from issuance of common stock11,833 910,392 922,225 
Dividends paid:
Common stock dividends(300,772)(300,772)
Balances at June 30, 2023$509,805 $28,085,297 $(112,032)$8,933,663 $(16,116,698)$(95,594)$619,482 $21,823,923 

















6


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)

 Six Months Ended June 30, 2022
 Common StockCapital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Noncontrolling
Interests
Total
Balances at January 1, 2022$448,605 $23,133,641 $(107,750)$8,663,736 $(14,380,915)$(121,316)$960,578 $18,596,579 
Comprehensive income:
Net income (loss)61,925 2,752 64,677 
Other comprehensive income (loss)(17,156)1,465 (15,691)
Total comprehensive income48,986 
Net change in noncontrolling interests(63,026)(128,305)(191,331)
Amounts related to stock incentive plans, net of forfeitures166 7,279 (4,768)2,677 
Net proceeds from issuance of common stock6,605 542,218 548,823 
Dividends paid:
Common stock dividends(273,668)(273,668)
Balances at March 31, 2022$455,376 $23,620,112 $(112,518)$8,725,661 $(14,654,583)$(138,472)$836,490 $18,732,066 
Comprehensive income:
Net income (loss)89,785 4,409 94,194 
Other comprehensive income (loss)(6,724)(15,116)(21,840)
Total comprehensive income72,354 
Net change in noncontrolling interests(6,760)118,793 112,033 
Adjustment to members' interest from change in ownership in Welltower OP46,861 (46,861) 
Amounts related to stock incentive plans, net of forfeitures20 6,551 827 7,398 
Net proceeds from issuance of common stock9,382 798,277 807,659 
Dividends paid:
Common stock dividends(277,615)(277,615)
Balances at June 30, 2022$464,778 $24,465,041 $(111,691)$8,815,446 $(14,932,198)$(145,196)$897,715 $19,453,895 

7


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended
June 30,
 20232022
Operating activities:    
Net income  $134,977 $161,423 
Adjustments to reconcile net income to net cash provided from (used in) operating activities:  
Depreciation and amortization  
681,057 614,383 
Other amortization expenses  
20,086 11,433 
Provision for loan losses, net3,233 (639)
Impairment of assets  
13,715  
Stock-based compensation expense  
19,960 13,466 
Loss (gain) on derivatives and financial instruments, net  
2,210 1,171 
Loss (gain) on extinguishment of debt, net  
6 591 
Loss (income) from unconsolidated entities
47,403 9,942 
Rental income less than (in excess of) cash received  
(71,997)(51,445)
Amortization related to above (below) market leases, net  
(248)(803)
Loss (gain) on real estate dispositions, net  
1,421 (19,402)
Loss (gain) on loss of control of subsidiary(65,485) 
Distributions by unconsolidated entities
6,895 9,590 
Increase (decrease) in accrued expenses and other liabilities  
(9,380)7,234 
Decrease (increase) in receivables and other assets  
8,450 (37,613)
Net cash provided from (used in) operating activities  792,303 719,331 
 
Investing activities:  
Cash disbursed for acquisitions, net of cash acquired
(424,094)(1,471,767)
Cash disbursed for capital improvements to existing properties
(204,978)(200,069)
Cash disbursed for construction in progress
(474,115)(286,427)
Capitalized interest  
(22,205)(11,866)
Investment in loans receivable
(76,397)(117,565)
Principal collected on loans receivable  
46,493 161,180 
Other investments, net of payments  
(95,819)3,919 
Contributions to unconsolidated entities  
(206,160)(307,513)
Distributions by unconsolidated entities  
125,176 13,641 
Proceeds from (payments on) derivatives  
3,933 27,302 
Proceeds from sales of real property  
1,950 103,904 
Net cash provided from (used in) investing activities  (1,326,216)(2,085,261)
Financing activities:  
Net increase (decrease) under unsecured credit facility and commercial paper
 29,065 
Net proceeds from issuance of senior unsecured notes1,011,427 1,040,232 
Net proceeds from the issuance of secured debt  
373,462 10,344 
Payments on secured debt  
(101,277)(226,854)
Net proceeds from the issuance of common stock  
1,333,908 1,357,561 
Payments for deferred financing costs and prepayment penalties  
(6,958)(4,081)
Contributions by noncontrolling interests(1)
181,272 38,065 
Distributions to noncontrolling interests(1)
(80,672)(214,288)
Cash distributions to stockholders  
(603,597)(549,842)
Other financing activities
(5,254)(6,586)
Net cash provided from (used in) financing activities  2,102,311 1,473,616 
Effect of foreign currency translation on cash and cash equivalents and restricted cash8,379 (12,190)
Increase (decrease) in cash, cash equivalents and restricted cash  1,576,777 95,496 
Cash, cash equivalents and restricted cash at beginning of period  722,292 346,755 
Cash, cash equivalents and restricted cash at end of period  $2,299,069 $442,251 
Supplemental cash flow information:
Interest paid$273,979 $207,031 
Income taxes paid (received), net1,157 5,462 
(1) Includes amounts attributable to redeemable noncontrolling interests.

8

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business
Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. We invest with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower Inc., a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties. 
As of May 24, 2022, we are structured as an umbrella partnership REIT under which substantially all of our business is conducted through Welltower OP LLC, the day-to-day management of which is exclusively controlled by Welltower Inc. Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP. Welltower's weighted average ownership in Welltower OP was 99.729% for the six months ended June 30, 2023. As of June 30, 2023, Welltower owned 99.727% of the issued and outstanding units of Welltower OP, with other investors owning the remaining 0.273% of outstanding units. We adjust the noncontrolling members' interest at the end of each period to reflect their interest in the net assets of Welltower OP.
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2023 are not necessarily an indication of the results that may be expected for the year ending December 31, 2023. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.
Impact of COVID-19 Pandemic & Government Grants
The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants in the future is uncertain and cannot be predicted with confidence. We have received government grants under the CARES Act, as well as under similar programs in the U.K. and Canada, primarily to cover increased expenses and lost revenue during the COVID-19 pandemic. We recognized $11,019,000 and $15,155,000 during the three and six months ended June 30, 2023, respectively, as compared to $21,804,000 and $27,564,000 during the three and six ended June 30, 2022, respectively. These grants represent a reduction to property operating expenses in our Consolidated Statements of Comprehensive Income. The amount of qualifying expenditures and lost revenue exceeded grant income recognized and we believe we have complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts are subject to recapture.
New Accounting Standards   
In March 2020, the FASB issued an amendment to the reference rate reform standard, which provides the option for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on contract modifications and hedge accounting. An example of such reform is the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. Entities that make this optional expedient election would not have to remeasure the contracts at the modification date or reassess the accounting treatment if certain criteria are met and would continue applying hedge accounting for relationships affected by reference rate reform. In December 2022, the FASB extended the date for which this guidance can be applied from December 31, 2022 to December 31, 2024. We continue to monitor developments related to the LIBOR transition and identification of an alternative, market-accepted rate.
3. Real Property Acquisitions and Development 
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income.
9

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
 Six Months Ended
 June 30, 2023June 30, 2022
Seniors Housing OperatingTriple-netOutpatient
Medical
TotalsSeniors Housing OperatingTriple-netOutpatient
Medical
Totals
Land and land improvements$4,426 $7,370 $60,527 $72,323 $130,282 $ $26,714 $156,996 
Buildings and improvements50,172 74,289 256,190 380,651 1,249,982 171 205,161 1,455,314 
Acquired lease intangibles970  39,090 40,060 77,705  26,836 104,541 
Construction in progress    108,141   108,141 
Right of use assets, net  927 927 169  3,852 4,021 
Total net real estate assets55,568 81,659 356,734 493,961 1,566,279 171 262,563 1,829,013 
Receivables and other assets2,089  358 2,447 6,091  260 6,351 
Total assets acquired(1)
57,657 81,659 357,092 496,408 1,572,370 171 262,823 1,835,364 
Secured debt(21,767) (40,953)(62,720)(219,067)  (219,067)
Lease liabilities  (953)(953)  (3,852)(3,852)
Accrued expenses and other liabilities(570) (8,071)(8,641)(11,937) (393)(12,330)
Total liabilities acquired(22,337) (49,977)(72,314)(231,004) (4,245)(235,249)
Noncontrolling interests (2)
    (101,885)(4)(664)(102,553)
Non-cash acquisition related activity(3)
    (25,795)  (25,795)
Cash disbursed for acquisitions35,320 81,659 307,115 424,094 1,213,686 167 257,914 1,471,767 
Construction in progress additions295,120 25,646 190,164 510,930 229,044 45,939 24,336 299,319 
Less: Capitalized interest(16,761)(2,416)(3,028)(22,205)(9,305)(2,031)(530)(11,866)
Accruals (4)
746 (9,384)(5,972)(14,610)(3,479) 2,453 (1,026)
Cash disbursed for construction in progress279,105 13,846 181,164 474,115 216,260 43,908 26,259 286,427 
Capital improvements to existing properties165,187 11,784 28,007 204,978 146,052 25,016 29,001 200,069 
Total cash invested in real property, net of cash acquired$479,612 $107,289 $516,286 $1,103,187 $1,575,998 $69,091 $313,174 $1,958,263 
(1) Excludes $5,491,000 of unrestricted and restricted cash acquired during the six months ended June 30, 2022.
(2) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests. For the six months ended June 30, 2022, 1,145,000 Welltower OP units were issued as a component of funding for certain transactions.
(3) Relates to the acquisition of assets recognized as investments in unconsolidated entities.
(4) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, offset by amounts paid in the current period.
Effective on April 1, 2022, our leasehold interest relating to the master lease with National Health Investors, Inc. ("NHI") for 17 properties assumed in conjunction with the Holiday Retirement acquisition was terminated as a result of the transition or sale of the properties by NHI. The lease termination was part of an agreement to resolve outstanding litigation with NHI. In conjunction with the agreement, a wholly owned subsidiary and the lessee on the master lease agreed to release $6,883,000 of cash to the landlord, which represents the net cash flow generated from the properties since we assumed the leasehold interest. Additionally, in connection with the lease termination, during the three months ended June 30, 2022, we recognized $58,621,000 in other income on our Consolidated Statements of Comprehensive Income from the derecognition of the right of use asset and related lease liability.
Construction Activity 
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
 Six Months Ended
 June 30, 2023June 30, 2022
Development projects:
Seniors Housing Operating
$140,865 $134,562 
Triple-net
141,142  
Outpatient Medical
21,173  
Total development projects
303,180 134,562 
Expansion projects
26,125  
Total construction in progress conversions$329,305 $134,562 
10

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
4. Real Estate Intangibles 
The following is a summary of our real estate intangibles, excluding those related to ground leases or classified as held for sale, as of the dates indicated (dollars in thousands):
 June 30, 2023December 31, 2022
Assets:
In place lease intangibles$1,802,091 $1,817,580 
Above market tenant leases66,354 57,203 
Lease commissions81,904 70,675 
Gross historical cost1,950,349 1,945,458 
Accumulated amortization(1,552,953)(1,484,048)
Net book value$397,396 $461,410 
Liabilities:
Below market tenant leases$82,084 $77,985 
Accumulated amortization(56,784)(52,701)
Net book value$25,300 $25,284 
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Rental income related to (above)/below market tenant leases, net$130 $351 $175 $736 
Amortization related to in place lease intangibles and lease commissions(53,774)(50,194)(109,925)(98,188)
5. Dispositions, Real Property Held for Sale and Impairment
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At June 30, 2023, 18 Seniors Housing Operating properties, one Triple-net property and one Outpatient Medical property with an aggregate real estate balance of $404,071,000 were classified as held for sale. In addition to the real property balances, secured debt balances of $171,711,000 and net other assets and (liabilities) of $26,950,000 are included in the Consolidated Balance Sheets related to the held for sale properties. Expected gross sales proceeds related to the held for sale properties are approximately $456,859,000.
During the six months ended June 30, 2023, we recorded $13,715,000 of impairment charges related to two Seniors Housing Operating properties and one Triple-net property classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell and one Seniors Housing Operating property classified as held for use for which the carrying value exceeded the estimated fair value. We did not record any impairment charges during the six months ended June 30, 2022.
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations are not reclassified on our Consolidated Statements of Comprehensive Income. We recognized income (loss) from continuing operations before income taxes and other items from properties sold or classified as held for sale as of June 30, 2023 of $65,362,000 and $54,381,000 for the three and six months ended June 30, 2023 and $1,588,000 and $2,602,000 for the same periods in 2022, respectively.
The following is a summary of our real property disposition activity for the periods presented (in thousands):
 Six Months Ended
 June 30, 2023June 30, 2022
Real estate dispositions:
Seniors Housing Operating
$243,695 $13,470 
Triple-net
2,028 70,571 
Total dispositions
245,723 84,041 
Gain (loss) on real estate dispositions, net(1,421)19,402 
Net other assets/(liabilities) disposed(624)461 
 Non-cash consideration (241,728) 
Cash proceeds from real estate dispositions$1,950 $103,904 

11

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Strategic Dissolution of Revera Joint Ventures
During the three months ended June 30, 2023, we entered into definitive agreements to dissolve our existing Revera joint venture relationships across the U.S., U.K. and Canada. The transactions include acquiring the remaining interests in 110 properties from Revera while simultaneously selling interests in 31 properties to Revera.
During the second quarter, we closed the U.K. portfolio portion of the transaction through the acquisition of the remaining ownership interest in 29 properties previously held in two separate consolidated joint venture structures in which we owned 75% and 90% of the interests in exchange for the disposition to Revera of our interests in four properties. In addition, we received cash from Revera of $107,341,000 relating to the net settlement of loans previously made to the joint ventures. Operations for the 29 retained properties were transitioned to Avery Healthcare.
Total proceeds related to the four properties disposed were $222,521,000, which included non-cash consideration from Revera of $241,728,000, comprised of the fair value of interests received by us of $198,837,000 and an allocation of Revera's noncontrolling interests of $42,891,000, partially offset by $9,049,000 of transaction-related expenses as well as the $10,158,000 of cash paid to equalize the value exchanged between the parties. We disposed of net real property owned of $224,208,000, resulting in a loss of $1,687,000 recognized within gain (loss) on real estate dispositions, net within our Consolidated Statements of Comprehensive Income. Consideration transferred to acquire the additional interests in the 29 properties was comprised of the fair value of interests transferred by us of $198,837,000 and $5,776,000 of cash paid for transaction-related expenses. We derecognized $180,497,000 of noncontrolling interests and $22,270,000 of liabilities previously due to Revera with an adjustment of $1,846,000 recognized in capital in excess of par value. The non-cash investing activity with respect to the sale of the four properties and non-cash financing activity with respect to the acquisition of Revera's interests in the 29 properties has been excluded from our Consolidated Statement of Cash Flows.
In July, we closed transactions related primarily to our U.S portfolio through (i) the acquisition of ten properties currently under development or recently developed by Sunrise Senior Living, previously held 34% by us/66% by Revera within an equity method joint venture for an additional investment of approximately $286 million, (ii) the disposition of our minority interests in 12 U.S. properties and one Canadian development project for approximately $216 million, and (iii) the disposition of our 34% interest in the Sunrise Senior Living management company. During the three months ended June 30, 2023, we recognized an impairment charge of $27,708,000 in income from unconsolidated entities on our Consolidated Statements of Comprehensive Income based on estimated sales proceeds for the sale of the Sunrise Senior Living management company. Operations for two of the now wholly-owned properties, along with operations for 26 existing wholly-owned properties, transitioned to Oakmont Management Group.
We anticipate closing the remainder of the transaction related to our Canadian portfolio before December 31, 2023. The Canadian portfolio consists of 85 properties in a joint venture owned 75% by us and 25% by Revera. As a part of the transaction we intend to acquire Revera's interest in 71 properties and sell our interests in the remaining 14 properties.
Genesis HealthCare
As part of the substantial exit of the Genesis HealthCare operating relationship, which we disclosed on March 2, 2021, we transitioned the sublease of a portfolio of seven facilities from Genesis HealthCare to Complete Care Management in the second quarter of 2021. As part of the March 2021 transaction, we entered into a forward sale agreement for the seven properties valued at $182,618,000, which was expected to close when the Welltower-held purchase option became exercisable. As of March 31, 2023, the right of use assets related to the properties were $115,359,000 and were reflected as held for sale with the corresponding lease liabilities of $66,530,000 on our Consolidated Balance Sheet.
On May 1, 2023, we executed a series of transactions that included the assignment of the leasehold interest to a newly formed tri-party unconsolidated joint venture with Aurora Health Network, Peace Capital (an affiliate of Complete Care Management) and us, and culminated with the closing of the purchase option by the joint venture. The transactions resulted in net cash proceeds to us of $104,240,000 (excluded from the dispositions table above) after our retained interest of $11,571,000 in the joint venture and a gain from the loss of control and derecognition of the leasehold interest of $65,485,000, which we recorded in other income within our Consolidated Statements of Comprehensive Income.
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.


12

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The components of lease expense were as follows for the periods presented (in thousands):
Six Months Ended
 ClassificationJune 30, 2023June 30, 2022
Operating lease cost: (1)
Real estate lease expenseProperty operating expenses$11,093 $11,209 
Non-real estate investment lease expenseGeneral and administrative expenses3,586 2,101 
Finance lease cost:
Amortization of leased assetsProperty operating expenses3,628 3,171 
Interest on lease liabilitiesInterest expense1,980 2,937 
Sublease incomeRental income(3,933)(5,587)
Total $16,354 $13,831 
(1) Includes short-term leases which are immaterial.
Supplemental balance sheet information related to leases in which we are the lessee is as follows (in thousands):
 ClassificationJune 30, 2023December 31, 2022
Right of use assets:
Operating leases - real estateRight of use assets, net$284,601 $287,984 
Finance leases - real estateRight of use assets, net37,715 35,958 
Real estate right of use assets, net322,316 323,942 
Operating leases - non-real estate investmentsReceivables and other assets8,433 10,119 
Finance leases - held for sale (1)
Real property held for sale, net of accumulated depreciation 116,453 
Total right of use assets, net$330,749 $450,514 
Lease liabilities:
Operating leases$299,377 $302,360 
Financing leases49,393 113,464 
Total$348,770 $415,824 
(1) During the quarter ended June 30, 2023, we contributed finance leases at seven properties which was previously classified as held for sale into a newly formed unconsolidated joint venture, which recognized the purchase option within the leases. See Note 5 for further discussion.
Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. 
Leases in our Triple-net and Outpatient Medical portfolios recognized under ASC 842, "Leases" (ASC 842), typically include some form of operating expense reimbursement by the tenant. For the six months ended June 30, 2023, we recognized $767,498,000 of rental income related to operating leases, of which $108,566,000 was for variable lease payments that primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. For the six months ended June 30, 2022, we recognized $717,801,000 of rental income related to operating leases, of which $96,309,000 was for variable lease payments.
For the majority of our Seniors Housing Operating segment, revenue from resident fees and services is predominantly service-based, and as such, resident agreements are accounted for under ASC 606, "Revenue from Contracts with Customers." Within that reportable segment, we also recognize revenue from residential seniors apartment leases in accordance with ASC 842. The amount of revenue related to these leases was $222,452,000 and $198,052,000 for the six months ended June 30, 2023 and 2022, respectively.
7. Loans Receivable
Loans receivable are recorded on our Consolidated Balance Sheets in real estate loans receivable, net of allowance for credit losses, or for non-real estate loans receivable, in receivables and other assets. Real estate loans receivable consists of mortgage loans and other real estate loans which are primarily collateralized by a first, second or third mortgage lien, a leasehold mortgage on, or an assignment of the partnership interest in, the related properties, as well as corporate guarantees and/or personal guarantees. Non-real estate loans are generally corporate loans with no real estate backing. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of the risk of credit loss. Accrued interest receivable was $26,641,000 and $22,878,000 as of June 30, 2023 and December 31, 2022, respectively, and is included in receivables and other assets on the Consolidated Balance Sheets. The following is a summary of our loans receivable (in thousands):

13

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 June 30, 2023December 31, 2022
Mortgage loans$738,496 $707,464 
Other real estate loans239,920 195,566 
Allowance for credit losses on real estate loans receivable(12,907)(12,186)
Real estate loans receivable, net of credit allowance965,509 890,844 
Non-real estate loans470,786 441,231 
Allowance for credit losses on non-real estate loans receivable(173,433)(152,063)
Non-real estate loans receivable, net of credit allowance297,353 289,168 
Total loans receivable, net of credit allowance$1,262,862 $1,180,012 
The following is a summary of our loan activity for the periods presented (in thousands):    
 Six Months Ended
 June 30, 2023June 30, 2022
Advances on loans receivable$76,397 $117,565 
Less: Receipts on loans receivable46,493 161,180 
Net cash advances (receipts) on loans receivable$29,904 $(43,615)
The allowance for credit losses on loans receivable is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the credit allowance is based on a quarterly evaluation of each of these loans, including general economic conditions and estimated collectability of loan payments. We evaluate the collectability of our loans receivable based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral.
A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans we identified as having deteriorated credit quality, we determine the amount of credit loss on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, we will return these loans to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance.
For the remaining loans we assess credit loss on a collective pool basis and use our historical loss experience for similar loans to determine the reserve for credit losses. The following is a summary of our loans by credit loss category (in thousands):
June 30, 2023
Loan categoryYears of OriginationLoan Carrying ValueAllowance for Credit LossNet Loan BalanceNo. of Loans
Deteriorated loans2007 - 2023$213,105 $(169,978)$43,127 8 
Collective loan pool2007 - 2018216,440 (2,878)213,562 12 
Collective loan pool201923,397 (311)23,086 4 
Collective loan pool202033,891 (451)33,440 6 
Collective loan pool2021783,161 (10,339)772,822 14 
Collective loan pool2022118,720 (1,579)117,141 29 
Collective loan pool202360,488 (804)59,684 7 
Total loans$1,449,202 $(186,340)$1,262,862 80 
The total allowance for credit losses balance is deemed sufficient to absorb expected losses relating to our loan portfolio. The following is a summary of the allowance for credit losses on loans receivable for the periods presented (in thousands):                            
Six Months Ended
June 30, 2023June 30, 2022
Balance at beginning of period$164,249 $166,785 
Provision for loan losses, net3,233 (639)
Purchased deteriorated loan19,077  
Foreign currency translation(219)(1,063)
Balance at end of period$186,340 $165,083 
14

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

8. Investments in Unconsolidated Entities
We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. Our share of the results of operations for these properties has been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands): 
 
Percentage Ownership (1)
June 30, 2023December 31, 2022
Seniors Housing Operating
10% to 95%
$1,271,079 $1,171,307 
Triple-net
10% to 88%
145,982 111,812 
Outpatient Medical
15% to 50%
233,072 216,671 
Total$1,650,133 $1,499,790 
(1) As of June 30, 2023 and includes ownership of investments classified as liabilities and excludes ownership of in substance real estate.
At June 30, 2023, the aggregate unamortized basis difference of our joint venture investments of $149,524,000 is primarily attributable to the difference between the amount for which we purchased our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the joint venture. This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.
We have made loans related to 22 properties as of June 30, 2023 for the development and construction of certain properties that are classified as in substance real estate investments and have a carrying value of $764,799,000. We believe that such borrowers typically represent variable interest entities ("VIE" or "VIEs") in accordance with ASC 810, "Consolidation." VIEs are required to be consolidated by their primary beneficiary, which is the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. We have concluded that we are not the primary beneficiary of such borrowers, therefore, the loan arrangements were assessed based on, among other factors, the amount and timing of expected residual profits, the estimated fair value of the collateral and the significance of the borrower's equity in the project. Based on these assessments, the arrangements have been classified as in substance real estate investments. We expect to fund an additional $105,405,000 related to these investments.
9. Credit Concentration
We use consolidated net operating income (“NOI”) as our credit concentration metric. See Note 18 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the six months ended June 30, 2023, excluding our share of NOI in unconsolidated entities (dollars in thousands):
Concentration by relationship: (1)
Number of PropertiesTotal NOI
Percent of NOI (2)
Integra Healthcare Properties
147 $107,789 8%
Sunrise Senior Living109 86,025 7%
Cogir Management Corporation48 45,814 3%
StoryPoint Senior Living75 45,617 3%
HC-One Group (3)
1 41,559 3%
Remaining portfolio1,398 982,978 76%
Totals1,778 $1,309,782 100%
(1) Integra Healthcare Properties and HC-One Group are in our Triple-net segment. Sunrise Senior Living and Cogir Management Corporation are in our Seniors Housing Operating segment. StoryPoint Senior Living operates assets in both our Seniors Housing Operating and Triple-net segments.
(2) NOI with our top five relationships comprised 30% of total NOI for the year ended December 31, 2022.
(3) In addition to the one property, HC-One Group is the borrower on a £525,471,000 loan as of June 30, 2023, which is included in NOI.
10. Borrowings Under Credit Facilities and Commercial Paper Program 
At June 30, 2023, we had a primary unsecured credit facility with a consortium of 31 banks that included a $4,000,000,000 unsecured revolving credit facility, a $1,000,000,000 unsecured term credit facility and a $250,000,000 Canadian-denominated unsecured term credit facility. The unsecured revolving credit facility is comprised of a $1,000,000,000 tranche that matures on June 4, 2026 (none outstanding at June 30, 2023) and a $3,000,000,000 tranche that matures on June 4, 2025 (none outstanding at June 30, 2023). The term credit facilities mature on July 19, 2026. Each tranche of the revolving facility and term loans may be extended for two successive terms of six months at our option. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $1,000,000,000 unsecured term credit facility by up to an additional $1,250,000,000, in the aggregate, and the $250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $250,000,000. The primary unsecured credit facility also allows us to borrow up to $1,000,000,000 in alternate currencies (none outstanding at June 30, 2023). Borrowings under the unsecured revolving credit facility are subject to interest

15

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

payable at the applicable margin over the secured overnight financing rate ("SOFR") interest rate. Based on our current credit ratings, the loans under the unsecured revolving credit facility currently bear interest at 0.775% over the adjusted SOFR rate at June 30, 2023. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on our debt ratings and was 0.15% at June 30, 2023. 
Under the terms of our commercial paper program, we may issue unsecured commercial paper notes with maturities that vary, but do not exceed 397 days from the date of issue, up to a maximum aggregate face or principal amount outstanding at any time of $1,000,000,000 (none outstanding at June 30, 2023).
The following information relates to aggregate borrowings under the unsecured revolving credit facility and commercial paper program for the periods presented (dollars in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Balance outstanding at quarter end$$354,000 $$354,000
Maximum amount outstanding at any month end$$1,135,000 $205,000$1,135,000
Average amount outstanding (total of daily principal balances divided by days in period)$$754,337 $32,735$857,328
Weighted average interest rate (actual interest expense divided by average borrowings outstanding) %1.36 %5.05 %0.90 %
 
11. Senior Unsecured Notes and Secured Debt 
At June 30, 2023, the annual principal payments due on our debt obligations were as follows (in thousands):
Senior
Unsecured Notes (1,2)
Secured
Debt (3)
Totals
2023$ $398,560 $398,560 
20241,350,000 470,448 1,820,448 
20251,260,000 298,553 1,558,553 
2026700,000 144,144 844,144 
2027 (4, 5)
1,915,659 190,356 2,106,015 
Thereafter (6, 7)
8,469,445 994,530 9,463,975 
Total principal balance13,695,104 2,496,591 16,191,695 
Unamortized discounts and premiums, net(26,710) (26,710)
Unamortized debt issuance costs, net(81,341)(20,982)(102,323)
Fair value adjustments and other, net(56,265)(15,260)(71,525)
Total carrying value of debt$13,530,788 $2,460,349 $15,991,137 
(1) Annual interest rates range from 2.05% to 6.50%.
(2) All senior unsecured notes with the exception of the $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 have been issued by Welltower OP and are fully and unconditionally guaranteed by Welltower. The $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 have been issued through private placement by a wholly-owned subsidiary of Welltower OP and are fully and unconditionally guaranteed by Welltower OP.
(3) Annual interest rates range from 1.25% to 8.25%. Gross real property value of the properties securing the debt totaled $5,371,352,000 at June 30, 2023.
(4) Includes a $1,000,000,000 unsecured term loan and a $250,000,000 Canadian-denominated unsecured term loan (approximately $188,936,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2023). Both term loans mature on July 19, 2026 and may be extended for two successive terms of six months at our option. The loans bear interest at adjusted SOFR plus 0.85% (6.10% at June 30, 2023) and Canadian Dealer Offered Rate plus 0.85% (6.10% at June 30, 2023), respectively.
(5) Includes a $300,000,000 Canadian-denominated 2.95% senior unsecured notes due 2027 (approximately $226,723,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2023).
(6) Includes a £550,000,000 4.80% senior unsecured notes due 2028 (approximately $698,995,000 based on the Pounds Sterling/U.S. Dollar exchange rate in effect on June 30, 2023).
(7) Includes a £500,000,000 4.50% senior unsecured notes due 2034 (approximately $635,450,000 based on the Pounds Sterling/U.S. Dollar exchange rate in effect on June 30, 2023).

16

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):
 Six Months Ended
 June 30, 2023June 30, 2022
 Weighted Avg.Weighted Avg.
 AmountInterest RateAmountInterest Rate
Beginning balance$12,584,529 4.06%$11,707,961 3.67%
Debt issued1,035,000 2.75%1,050,000 3.08%
Foreign currency75,575 4.60%(143,634)4.14%
Ending balance$13,695,104 4.00%$12,614,327 3.68%
Welltower, the parent entity that consolidates Welltower OP and all other subsidiaries, fully and unconditionally guarantees to each holder of all series of senior unsecured notes issued by Welltower OP that the principal of and premium, if any, and interest on the notes will be promptly paid in full when due, whether at the applicable maturity date, by acceleration or redemption or otherwise, and interest on the overdue principal of and interest on the notes, if any, if lawful, and all other obligations of Welltower OP to the holders of the notes will be promptly paid in full or performed. Welltower’s guarantees of such notes are its senior unsecured obligation and rank equally with all of Welltower’s other future unsecured senior indebtedness and guarantees from time to time outstanding. Welltower’s guarantees of such notes are effectively subordinated to all liabilities of its subsidiaries and to its secured indebtedness to the extent of the assets securing such indebtedness. Because Welltower conducts substantially all of its business through its subsidiaries, Welltower's ability to make required payments with respect to the guarantees depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries, whether by dividends, loans, distributions or other payments.
We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, subject to certain contractual restrictions, at a redemption price equal to the sum of: (i) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (ii) any “make-whole” amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. 
Exchangeable Senior Unsecured Notes
In May 2023, Welltower OP issued $1,035,000,000 aggregate principal amount of 2.75% exchangeable senior unsecured notes maturing May 15, 2028 (the "Exchangeable Notes" or the "Notes") unless earlier exchanged, purchased or redeemed. The Exchangeable Notes will pay interest semi-annually in arrears on May 15 and November 15 of each year. The net proceeds from the offering of the Exchangeable Notes were approximately $1,011,427,000 after deducting the underwriting fees and other expenses. During the quarter ended June 30, 2023, we recognized approximately $3,953,000 of contractual interest expense and amortization of issuance costs of $693,000 related to the Exchangeable Notes. Unamortized issuance costs were $22,880,000 as of June 30, 2023.
Prior to the close of business on the business day immediately preceding November 15, 2027, the Notes are exchangeable at the option of the holders only upon certain circumstances and during certain periods. On or after November 15, 2027, the Notes will be exchangeable at the option of the holders at any time prior to the close of business on the second scheduled trading day preceding the maturity date. Welltower OP will settle exchanges of the Notes by delivering cash up to the principal amount of the Notes exchanged and, in respect of the remainder of the exchanged value, if any, in excess thereof, cash or shares of Welltower's common stock, or a combination thereof, at the election of Welltower OP. The exchange rate initially equals 10.4808 shares of common stock per $1,000 principal amount of Notes (equivalent to an exchange price of approximately $95.41 per share of common stock). The exchange rate is subject to adjustment upon the occurrence of certain events, but will not be adjusted for any accrued and unpaid interest.
Welltower OP may redeem the Notes, at its option, in whole or in part, on any business day on or after May 20, 2026, if the last reported sales price of the common stock has been at least 130% of the exchange price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Welltower OP provides notice of redemption. The redemption price will be equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to but excluding the redemption date.

17

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands): 
 Six Months Ended
 June 30, 2023June 30, 2022
 Weighted Avg.Weighted Avg.
 AmountInterest RateAmountInterest Rate
Beginning balance$2,129,954 4.33%$2,202,312 3.03%
Debt issued373,462 5.05%10,344 3.23%
Debt assumed73,671 3.60%221,159 4.32%
Debt extinguished(72,496)3.99%(196,504)4.15%
Principal payments(28,781)3.90%(30,350)3.29%
Foreign currency20,781 4.07%(6,335)2.97%
Ending balance$2,496,591 4.70%$2,200,626 3.43%
Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2023, we were in compliance in all material respects with all of the covenants under our debt agreements. 
12. Derivative Instruments
We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our non-U.S. investments and interest rate risk related to our capital structure. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, cross currency swap contracts, interest rate swaps, interest rate locks and debt issued in foreign currencies to offset a portion of these risks.
Cash Flow Hedges and Fair Value Hedges of Interest Rate Risk
We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements are used to hedge the variable cash flows associated with variable-rate debt.
Interest rate swaps designated as fair value hedges involve the receipt of fixed amounts from a counterparty in exchange for our variable-rate payments. These interest rate swap agreements hedge the exposure to changes in the fair value of fixed-rate debt attributable to changes in the designated benchmark interest rate. For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative instrument, as well as the offsetting loss or gain on the hedged item attributable to the hedged risk, are recognized in earnings. We record the gain or loss on the hedged items in interest expense, the same line item as the offsetting loss or gain on the related interest rate swaps. During the six months ended June 2022, we entered into a $550,000,000 fixed to floating swap in connection with our March 2022 senior note issuance. The carrying amount of the notes, exclusive of the hedge, is $545,626,000. The fair value of the swap as of June 30, 2023 was ($56,265,000) and was recorded as a derivative liability with an offset to senior unsecured notes on our Consolidated Balance Sheets.
Periodically, we enter into and designate interest rate locks to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized into earnings over the life of the related debt, except where a material amount is deemed to be ineffective, which would be immediately recognized in the Consolidated Statements of Comprehensive Income. Approximately $2,562,000 of losses, which are included in other comprehensive income ("OCI"), are expected to be reclassified into earnings in the next 12 months.
Foreign Currency Forward Contracts and Cross Currency Swap Contracts Designated as Net Investment Hedges
We use foreign currency forward and cross currency forward swap contracts to hedge a portion of the net investment in foreign subsidiaries against fluctuations in foreign exchange rates. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI.
During the six months ended June 30, 2023 and 2022, we settled certain net investment hedges generating cash proceeds of $1,994,000 and $27,267,000, respectively. The balance of the cumulative translation adjustment will be reclassified to earnings if the hedged investment is sold or substantially liquidated.


18

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Derivative Contracts Undesignated
We use foreign currency exchange contracts to manage existing exposures to foreign currency exchange risk. Gains and losses resulting from the changes in fair value of these instruments are recorded in interest expense on the Consolidated Statements of Comprehensive Income and are substantially offset by net revaluation impacts on foreign currency denominated balance sheet exposures. In addition, we have several interest rate cap contracts related to variable rate secured debt agreements. Gains and losses resulting from the changes in fair values of these instruments are also recorded in interest expense.
Equity Warrants
We received equity warrants through our lending activities, which were accounted for as loan origination fees. The warrants provide us the right to participate in the capital appreciation of the underlying HC-One Group real estate portfolio above a designated price upon liquidation and contain net settlement terms qualifying as derivatives under ASC Topic 815. The warrants are classified within receivables and other assets on our Consolidated Balance Sheets. These warrants are measured at fair value with changes in fair value being recognized within gain (loss) on derivatives and financial instruments in our Consolidated Statements of Comprehensive Income.
The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands): 
 June 30, 2023December 31, 2022
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars$1,075,000 $1,075,000 
Denominated in Pound Sterling£1,890,708 £1,890,708 
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars$250,000 $250,000 
Denominated in Pound Sterling£1,050,000 £1,050,000 
Interest rate swaps designated as cash flow hedges:
Denominated in U.S Dollars (1)
$375,000 $25,000 
Interest rate swaps designated as fair value hedges:
Denominated in U.S Dollars$550,000 $550,000 
Derivative instruments not designated:
Interest rate caps denominated in U.S. Dollars$26,137 $26,137 
Foreign currency exchange contracts denominated in Canadian Dollars$80,000 $80,000 
(1) At June 30, 2023 the maximum maturity date was March 31, 2024.
The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
DescriptionLocation2023202220232022
Gain (loss) on derivative instruments designated as hedges recognized in incomeInterest expense$4,759 $9,042 $9,378 $15,026 
Gain (loss) on derivative instruments not designated as hedges recognized in incomeInterest expense$(1,175)$1,827 $(1,429)$1,134 
Gain (loss) on equity warrants recognized in incomeGain (loss) on derivatives and financial instruments, net$(1,242)$1,904 $(2,127)$(520)
Gain (loss) on derivative and financial instruments designated as hedges recognized in OCIOCI$(85,884)$284,081 $(155,622)$336,021 
13. Commitments and Contingencies
At June 30, 2023, we had 24 outstanding letter of credit obligations totaling $72,544,000 and expiring between 2023 and 2024. At June 30, 2023, we had outstanding construction in progress of $1,108,773,000 and committed to providing additional funds of approximately $1,852,975,000 to complete construction. Additionally, at June 30, 2023, we had outstanding investments classified as in substance real estate of $764,799,000 and committed to provide additional funds of $105,405,000 (see Note 8 for additional information). Purchase obligations also include $78,947,000 of contingent purchase obligations to fund capital improvements. Rents due from the tenants are increased to reflect the additional investment in the property.
19

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
14. Stockholders’ Equity 
The following is a summary of our stockholders’ equity capital accounts as of the dates indicated: 
 June 30, 2023December 31, 2022
Preferred Stock, $1.00 par value:
Authorized shares50,000,000 50,000,000 
Issued shares  
Outstanding shares  
Common Stock, $1.00 par value:
Authorized shares700,000,000 700,000,000 
Issued shares509,934,840 492,283,488 
Outstanding shares508,159,453 490,508,937 
Common Stock In May 2023, we entered into an equity distribution agreement whereby we can offer and sell up to $2,532,139,425 aggregate amount of our common stock ("ATM Program"). The ATM Program also allows us to enter into forward sale agreements (none outstanding at June 30, 2023). As of June 30, 2023, we had $1,659,273,000 of remaining capacity under the ATM Program. During July 2023, we sold 10,532,714 shares of common stock under our ATM Program.
The following is a summary of our common stock issuances during the six months ended June 30, 2023 and 2022 (dollars in thousands, except shares and average price amounts): 
 Shares IssuedAverage PriceGross ProceedsNet Proceeds
2022 Option exercises299 $66.89 $20 $20 
2022 ATM Program issuances15,986,251 86.26 1,379,002 1,357,541 
2022 Stock incentive plans, net of forfeitures143,210 — — 
2022 Totals16,129,760 $1,379,022 $1,357,561 
2023 Option exercises1,708 $63.65 $109 $109 
2023 ATM Program issuances17,435,154 76.90 1,340,727 1,333,799 
2023 Redemption of OP Units and DownREIT Units
272,494 — — 
2023 Stock incentive plans, net of forfeitures(58,840)— — 
2023 Totals17,650,516 $1,340,836 $1,333,908 
Dividends The following is a summary of our dividend payments (in thousands, except per share amounts): 
 Six Months Ended
 June 30, 2023June 30, 2022
Per ShareAmountPer ShareAmount
Common stock$1.22 $602,601 $1.22 $551,283 
Accumulated Other Comprehensive Income The following is a summary of accumulated other comprehensive income (loss) as of the dates presented (in thousands):
June 30, 2023December 31, 2022
Foreign currency translation$(935,582)$(1,115,317)
Derivative and financial instruments designated as hedges839,988 995,610 
Total accumulated other comprehensive income (loss)$(95,594)$(119,707)
15. Stock Incentive Plans
In March 2022, our Board of Directors approved the 2022 Long-Term Incentive Plan ("2022 Plan"), which authorizes up to 10,000,000 shares of common stock or units to be issued at the discretion of the Compensation Committee of the Board of Directors. Awards granted after March 28, 2022 will be issued out of the 2022 Plan. The awards granted under the 2016 Long-Term Incentive Plan continue to vest and options expire ten years from the date of grant. Our non-employee directors, officers and key employees are eligible to participate in the 2022 Plan. The 2022 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock units, deferred stock units, performance units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted stock units generally range from three to five years. Options expire ten years from the date of grant. Stock-based compensation expense totaled $10,504,000 and $19,960,000 for the three and six months ended June 30, 2023, and $6,021,000 and $13,466,000 for the same periods in 2022, respectively.
20

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
16. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):
Three Months Ended June 30,Six Months Ended June 30,
 2023202220232022
Numerator for basic earnings per share - net income (loss) attributable to common stockholders
$103,040 $89,784 $128,713 $151,709 
Adjustment for net income (loss) attributable to OP Units and DownREIT Units(157)228 (167)106 
Numerator for diluted earnings per share
$102,883 $90,012 $128,546 $151,815 
Denominator for basic earnings per share - weighted average shares499,023 454,327 495,561 450,865 
Effect of dilutive securities:
Employee stock options
28 40 16 36 
Non-vested restricted shares and units1,044 1,166 882 1,070 
OP Units and DownREIT Units
1,850 1,526 1,818 1,461 
Employee stock purchase program
25 23 28 23 
Dilutive potential common shares2,947 2,755 2,744 2,590 
Denominator for diluted earnings per share - adjusted weighted average shares
501,970 457,082 498,305 453,455 
Basic earnings per share$0.21 $0.20 $0.26 $0.34 
Diluted earnings per share$0.20 $0.20 $0.26 $0.33 
As of June 30, 2022, outstanding forward sales agreements for the sale of 17,636,290 shares were not included in the computation of diluted earnings per share because such forward sales were anti-dilutive for the period. There were no outstanding forward sales agreements as of June 30, 2023. As of June 30, 2023, the Exchangeable Notes were not included in the computation of diluted earnings per share as they were anti-dilutive for the three and six month periods ended June 30, 2023.
17. Disclosure about Fair Value of Financial Instruments 
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A three-level valuation hierarchy exists for disclosures of fair value measurements based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument's categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 for additional information. The three levels are defined below: 
Level 1 - Quoted prices in active markets for identical assets or liabilities. 
Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.                                         
Mortgage Loans, Other Real Estate Loans and Non-real Estate Loans Receivable — The fair value of mortgage loans, other real estate loans and non-real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.
Cash and Cash Equivalents and Restricted Cash — The carrying amount approximates fair value. 
Equity Securities — Equity securities are recorded at their fair value based on Level 1 publicly available trading prices. 
Equity Warrants The fair value of equity warrants is estimated using Level 3 inputs and includes data points such as enterprise value of the underlying HC-One Group real estate portfolio, marketability discount for private company warrants,
21

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
dividend yield, volatility and risk-free rate. The enterprise value is driven by projected cash flows, weighted average cost of capital and a terminal capitalization rate.
Borrowings Under Primary Unsecured Credit Facility and Commercial Paper Program — The carrying amount of the primary unsecured credit facility and commercial paper program approximates fair value because the borrowings are interest rate adjustable. 
Senior Unsecured Notes — The fair value of the senior unsecured notes payable is estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable. 
Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable. 
Foreign Currency Forward Contracts, Interest Rate Swaps and Cross Currency Swaps — Foreign currency forward contracts, interest rate swaps and cross currency swaps are recorded in other assets or other liabilities on the balance sheet at fair value that is derived from observable market data, including yield curves and foreign exchange rates.
Redeemable DownREIT Unitholder Interests — Our redeemable DownREIT Unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs unless the fair value is below the initial amount, in which case the redeemable DownREIT Unitholder interests are recorded at the initial amount adjusted for distributions to the unitholders and income or loss attributable to the unitholders. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances. 
The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):
 June 30, 2023December 31, 2022
 Carrying AmountFair ValueCarrying AmountFair Value
Financial assets:
Mortgage loans receivable$728,751 $779,462 $697,906 $739,159 
Other real estate loans receivable236,758 236,426 192,938 190,977 
Equity securities27 27 111 111 
Cash and cash equivalents2,203,788 2,203,788 631,681 631,681 
Restricted cash95,281 95,281 90,611 90,611 
Non-real estate loans receivable297,353 285,144 289,168 277,601 
Foreign currency forward contracts, interest rate swaps and cross currency swaps113,285 113,285 191,357 191,357 
Equity warrants29,852 29,852 30,436 30,436 
Financial liabilities:
Senior unsecured notes$13,530,788 $12,596,885 $12,437,273 $11,381,873 
Secured debt2,460,349 2,384,444 2,110,815 2,054,889 
Foreign currency forward contracts, interest rate swaps and cross currency swaps68,590 68,590 55,727 55,727 
Redeemable DownREIT Unitholder interests$69,908 $69,908 $75,355 $75,355 
Items Measured at Fair Value on a Recurring Basis 
The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):
 Fair Value Measurements as of June 30, 2023
 TotalLevel 1Level 2Level 3
Equity securities$27 $27 $ $ 
Equity warrants29,852   29,852 
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability) (1)
44,695  44,695  
Totals $74,574 $27 $44,695 $29,852 
(1) Please see Note 12 for additional information.
22

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following table summarizes the change in fair value for equity warrants using unobservable Level 3 inputs for the periods presented (in thousands):
Six Months Ended
 June 30, 2023June 30, 2022
Beginning balance$30,436 $41,909 
Mark-to-market adjustment(2,126)(520)
Foreign currency1,542 (3,985)
Ending balance$29,852 $37,404 
The most significant assumptions utilized in the valuation of the equity warrants are the cash flows of the underlying HC-One Group enterprise, as well as the terminal capitalization rate which was 11.0% and 9.5% at June 30, 2023 and 2022, respectively.
Items Measured at Fair Value on a Nonrecurring Basis 
In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis that are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired, exchanged or assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 7 for impairments of loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of loans receivable using projected payoff valuations based on the expected future cash flows and/or the estimated fair value of collateral, net of sales costs, if the repayment of the loan is expected to be provided solely by the collateral. We estimate the fair value of secured debt assumed in asset acquisitions using current interest rates at which similar borrowings could be obtained on the transaction date. 
18. Segment Reporting
We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: Seniors Housing Operating, Triple-net and Outpatient Medical. Our Seniors Housing Operating properties include seniors apartments, assisted living, independent living/continuing care retirement communities, independent supportive living communities (Canada), care homes with and without nursing (U.K.) and combinations thereof that are owned and/or operated through RIDEA structures (see Note 19). Our Triple-net properties include the property types described above as well as long-term/post-acute care facilities. Under the Triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our Outpatient Medical properties are typically leased to multiple tenants and generally require a certain level of property management by us.
We evaluate performance based upon consolidated NOI of each segment. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.  
Non-segment revenue consists mainly of interest income on cash investments recorded in other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. All inter-segment transactions are eliminated.
23

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands): 
Three Months Ended June 30, 2023Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$1,159,449 $ $ $ $1,159,449 
Rental income 198,916 184,523  383,439 
Interest income2,095 36,520 95  38,710 
Other income2,895 66,692 1,574 12,719 83,880 
Total revenues1,164,439 302,128 186,192 12,719 1,665,478 
Property operating expenses885,187 10,598 58,697 4,190 958,672 
Consolidated net operating income (loss)279,252 291,530 127,495 8,529 706,806 
Depreciation and amortization220,428 55,234 66,283  341,945 
Interest expense16,136 (795)3,152 133,844 152,337 
General and administrative expenses   44,287 44,287 
Loss (gain) on derivatives and financial instruments, net 1,280   1,280 
Loss (gain) on extinguishment of debt, net  1  1 
Provision for loan losses, net1,867 591 (2) 2,456 
Impairment of assets 1,086   1,086 
Other expenses8,060 818 647 1,544 11,069 
Income (loss) from continuing operations before income taxes and other items32,761 233,316 57,414 (171,146)152,345 
Income tax (expense) benefit   (3,503)(3,503)
Income (loss) from unconsolidated entities(39,445)(630)(257) (40,332)
Gain (loss) on real estate dispositions, net(2,096)(72)  (2,168)
Income (loss) from continuing operations(8,780)232,614 57,157 (174,649)106,342 
Net income (loss)$(8,780)$232,614 $57,157 $(174,649)$106,342 
Total assets$22,074,247 $8,754,820 $7,049,214 $2,185,854 $40,064,135 
Three Months Ended June 30, 2022Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$1,009,999 $ $ $ $1,009,999 
Rental income 197,182 164,229  361,411 
Interest income1,683 35,392 65  37,140 
Other income59,528 1,786 2,028 644 63,986 
Total revenues1,071,210 234,360 166,322 644 1,472,536 
Property operating expenses789,299 11,491 50,648 2,645 854,083 
Consolidated net operating income (loss)281,911 222,869 115,674 (2,001)618,453 
Depreciation and amortization201,178 49,561 59,556  310,295 
Interest expense7,481 320 4,531 115,418 127,750 
General and administrative expenses   36,554 36,554 
Loss (gain) on derivatives and financial instruments, net (1,407)  (1,407)
Loss (gain) on extinguishment of debt, net400  4 199 603 
Provision for loan losses, net342 (176)(1) 165 
Other expenses29,249 463 

207 5,247 35,166 
Income (loss) from continuing operations before income taxes and other items43,261 174,108 51,377 (159,419)109,327 
Income tax (expense) benefit   (3,065)(3,065)
Income (loss) from unconsolidated entities(12,669)5,874 (263) (7,058)
Gain (loss) on real estate dispositions, net(1,224)(2,129)(179) (3,532)
Income (loss) from continuing operations29,368 177,853 50,935 (162,484)95,672 
Net income (loss)$29,368 $177,853 $50,935 $(162,484)$95,672 
24

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Six Months Ended June 30, 2023Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$2,291,134 $ $ $ $2,291,134 
Rental income 401,335 366,163  767,498 
Interest income4,646 70,283 186  75,115 
Other income5,340 68,575 4,674 13,871 92,460 
Total revenues2,301,120 540,193 371,023 13,871 3,226,207 
Property operating expenses1,768,971 22,321 117,062 8,071 1,916,425 
Consolidated net operating income (loss)532,149 517,872 253,961 5,800 1,309,782 
Depreciation and amortization440,835 109,762 130,460  681,057 
Interest expense27,623 (810)7,256 262,671 296,740 
General and administrative expenses   88,658 88,658 
Loss (gain) on derivatives and financial instruments, net 2,210   2,210 
Loss (gain) on extinguishment of debt, net  6  6 
Provision for loan losses, net1,794 1,441 (2) 3,233 
Impairment of assets12,629 1,086   13,715 
Other expenses25,639 3,285 1,194 3,696 33,814 
Income (loss) from continuing operations before income taxes and other items23,629 400,898 115,047 (349,225)190,349 
Income tax (expense) benefit   (6,548)(6,548)
Income (loss) from unconsolidated entities(55,034)7,802 (171) (47,403)
Gain (loss) on real estate dispositions, net(1,263)448 (606) (1,421)
Income (loss) from continuing operations(32,668)409,148 114,270 (355,773)134,977 
Net income (loss)$(32,668)$409,148 $114,270 $(355,773)$134,977 

Six Months Ended June 30, 2022Seniors Housing OperatingTriple-netOutpatient MedicalNon-segment / CorporateTotal
Resident fees and services$2,004,334 $ $ $ $2,004,334 
Rental income 393,183 324,618  717,801 
Interest income3,100 72,898 136  76,134 
Other income60,388 3,442 4,891 1,250 69,971 
Total revenues2,067,822 469,523 329,645 1,250 2,868,240 
Property operating expenses1,579,227 22,702 100,563 5,260 1,707,752 
Consolidated net operating income (loss)488,595 446,821 229,082 (4,010)1,160,488 
Depreciation and amortization393,971 103,065 117,347  614,383 
Interest expense15,131 634 9,098 224,583 249,446 
General and administrative expenses   74,260 74,260 
Loss (gain) on derivatives and financial
instruments, net
 1,171   1,171 
Loss (gain) on extinguishment of debt, net385  7 199 591 
Provision for loan losses, net609 (1,241)(7) (639)
Other expenses37,440 11,507 996 11,292 61,235 
Income (loss) from continuing operations before income taxes and other items41,059 331,685 101,641 (314,344)160,041 
Income tax (expense) benefit   (8,078)(8,078)
Income (loss) from unconsolidated entities(30,451)21,417 (908) (9,942)
Gain (loss) on real estate dispositions, net1,477 18,320 (395) 19,402 
Income (loss) from continuing operations12,085 371,422 100,338 (322,422)161,423 
Net income (loss)$12,085 $371,422 $100,338 $(322,422)$161,423 



25

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for the periods presented (dollars in thousands): 
 Three Months EndedSix Months Ended
 June 30, 2023June 30, 2022June 30, 2023June 30, 2022
Revenues:Amount%Amount%
Amount(1)
%Amount%
United States$1,392,512 83.7 %$1,218,879 82.7 %$2,688,534 83.3 %$2,357,895 82.2 %
United Kingdom154,028 9.2 %139,352 9.5 %301,904 9.4 %283,843 9.9 %
Canada118,938 7.1 %114,305 7.8 %235,769 7.3 %226,502 7.9 %
Total$1,665,478 100.0 %$1,472,536 100.0 %$3,226,207 100.0 %$2,868,240 100.0 %
Three Months EndedSix Months Ended
June 30, 2023June 30, 2022June 30, 2023June 30, 2022
Resident Fees and Services:Amount%Amount%
Amount(1)
%Amount%
United States$929,997 80.2 %$798,825 79.1 %$1,838,941 80.3 %$1,582,922 79.0 %
United Kingdom113,585 9.8 %99,626 9.9 %222,597 9.7 %200,716 10.0 %
Canada115,867 10.0 %111,548 11.0 %229,596 10.0 %220,696 11.0 %
Total$1,159,449 100.0 %$1,009,999 100.0 %$2,291,134 100.0 %$2,004,334 100.0 %
 As of
 June 30, 2023December 31, 2022
Assets:Amount%Amount%
United States$33,868,263 84.5 %$31,740,907 83.8 %
United Kingdom3,468,475 8.7 %3,476,793 9.2 %
Canada2,727,397 6.8 %2,675,533 7.0 %
Total$40,064,135 100.0 %$37,893,233 100.0 %
19. Income Taxes and Distributions 
We elected to be taxed as a REIT commencing with our first taxable year. To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes. 
Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor.” Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property.” A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years. 
Income taxes reflected in the financial statements primarily represents U.S. federal, state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The provision for income taxes for the six months ended June 30, 2023 and 2022 was primarily due to operating income or losses, offset by certain discrete items at our TRS entities. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and most of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. Subsequent to 2014, we transferred certain subsidiaries to the United Kingdom, while some wholly-owned direct and
26

WELLTOWER INC.
 NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
indirect subsidiaries remain in Luxembourg and Jersey. The company reflects current and deferred tax liabilities for any such withholding taxes incurred from this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the foreign, federal, state and local taxing authorities under applicable local laws.
20. Variable Interest Entities 
We have entered into joint ventures and have certain subsidiaries that are wholly owned by consolidated joint ventures and own certain seniors housing and outpatient medical assets which are deemed to be VIEs. We have concluded that we are the primary beneficiary of these VIEs based on a combination of operational control of the entities and the rights to receive residual returns or the obligation to absorb losses arising from the entities. Except for capital contributions associated with the initial entity formations, the entities have been and are expected to be funded from the ongoing operations of the underlying properties. Accordingly, such entities have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs in the aggregate (in thousands):
June 30, 2023December 31, 2022
Assets:
Net real estate investments$1,481,012 $1,499,078 
Cash and cash equivalents12,778 15,582 
Receivables and other assets24,157 9,949 
Total assets (1)
$1,517,947 $1,524,609 
Liabilities and equity:
Secured debt$155,359 $155,992 
Lease liabilities1,329 1,329 
Accrued expenses and other liabilities20,918 28,417 
Total equity1,340,341 1,338,871 
Total liabilities and equity$1,517,947 $1,524,609 
(1) Note that assets of the consolidated VIEs can only be used to settle obligations relating to such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs.
27

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
EXECUTIVE SUMMARY
   
Company Overview
Business Strategy
Key Transactions
 Key Performance Indicators, Trends and Uncertainties
Corporate Governance
 LIQUIDITY AND CAPITAL RESOURCES
   
Sources and Uses of Cash
Off-Balance Sheet Arrangements
Contractual Obligations
Capital Structure
Supplemental Guarantor Information
   
 RESULTS OF OPERATIONS
   
Summary
Seniors Housing Operating
Triple-net
Outpatient Medical
Non-Segment/Corporate
   
 OTHER
   
 Non-GAAP Financial Measures
 Critical Accounting Policies and Estimates
 Cautionary Statement Regarding Forward-Looking Statements
28

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read together with the Consolidated Financial Statements and related Notes thereto included in Item 1 of this report. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2022, including factors identified under the headings “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations."
On March 7, 2022, we announced our intent to complete an UPREIT reorganization. In February 2022, the company formerly known as Welltower Inc. ("Old Welltower") formed WELL Merger Holdco Inc. ("New Welltower") as a wholly-owned subsidiary, and New Welltower formed WELL Merger Holdco Sub Inc. ("Merger Sub") as a wholly-owned subsidiary. On April 1, 2022, Merger Sub merged with and into Old Welltower, with Old Welltower continuing as the surviving corporation and a wholly-owned subsidiary of New Welltower (the "Merger"). In connection with the Merger, Old Welltower's name was changed to "Welltower OP Inc.", and New Welltower inherited the name "Welltower Inc." Effective May 24, 2022, Welltower OP Inc. ("Welltower OP") converted from a Delaware corporation into a Delaware limited liability company named Welltower OP LLC (the "LLC Conversion"). Following the LLC Conversion, New Welltower's business continues to be conducted through Welltower OP and New Welltower does not have substantial assets or liabilities, other than through its investment in Welltower OP.
Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP.
Executive Summary
Company Overview
Welltower Inc. (NYSE:WELL), a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower owns interests in properties concentrated in major, high-growth markets in the United States ("U.S."), Canada and the United Kingdom ("U.K."), consisting of seniors housing and post-acute communities and outpatient medical properties.
Welltower is the initial member and majority owner of Welltower OP, with an approximate ownership interest of 99.727% as of June 30, 2023. All of our property ownership, development and related business operations are conducted through Welltower OP and Welltower has no material assets or liabilities other than its investment in Welltower OP. Welltower issues equity from time to time, the net proceeds of which it is obligated to contribute as additional capital to Welltower OP. All debt including credit facilities, senior notes and secured debt is incurred by Welltower OP, and Welltower has fully and unconditionally guaranteed all existing senior unsecured notes.
The following table summarizes our consolidated portfolio for the three months ended June 30, 2023 (dollars in thousands):
  Percentage ofNumber of
Type of Property
NOI (1)
NOIProperties
Seniors Housing Operating$279,252 40.0 %852 
Triple-net291,530 41.7 %568 
Outpatient Medical127,495 18.3 %358 
Totals$698,277 100.0 %1,778 
(1) Represents consolidated NOI and excludes our share of investments in unconsolidated entities. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount. See "Non-GAAP Financial Measures" below for additional information and reconciliation.
Business Strategy
Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in NOI and portfolio growth. To meet these objectives, we invest across the full spectrum of seniors housing and health care real estate and diversify our investment portfolio by property type, relationship and geographic location.
Substantially all of our revenues are derived from operating lease rentals, resident fees and services and interest earned on outstanding loans receivable. These items represent our primary sources of liquidity to fund distributions and depend upon the continued ability of our obligors to make contractual rent and interest payments to us and the profitability of our operating properties. To the extent that our obligors/partners experience operating difficulties and become unable to generate sufficient cash to make payments or operating distributions to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Additionally, the extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants in the future is uncertain and cannot be predicted with confidence.

29

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property. Our asset management process for seniors housing properties generally includes review of monthly financial statements and other operating data for each property, review of obligor/partner creditworthiness, property inspections and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. Our internal property management division manages and monitors the outpatient medical portfolio with a comprehensive process including review of tenant relations, lease expirations, the mix of health service providers, hospital/health system relationships, property performance, capital improvement needs and market conditions among other things. We evaluate the operating environment in each property’s market to determine the likely trend in operating performance of the facility. When we identify unacceptable trends, we seek to mitigate, eliminate or transfer the risk. Through these efforts, we generally aim to intervene at an early stage to address any negative trends, and in so doing, support both the collectability of revenue and the value of our investment.
In addition to our asset management and research efforts, we also aim to structure our relevant investments to mitigate payment risk. Operating leases and loans are normally credit enhanced by guarantees and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other real estate loans, operating leases or agreements between us and the obligor and its affiliates.
For the six months ended June 30, 2023, resident fees and services and rental income represented 71% and 24%, respectively, of total revenues. Substantially all of our operating leases are designed with escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.
Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, general and administrative expenses and other expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash.
We also continuously evaluate opportunities to finance future investments. New investments are generally funded from temporary borrowings under our unsecured revolving credit facility and commercial paper program, internally generated cash and the proceeds from investment dispositions. Our investments generate cash from NOI and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under our unsecured revolving credit facility and commercial paper program, has historically been provided through a combination of the issuance of public debt and equity securities and the incurrence or assumption of secured debt.
Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. It is also likely that investment dispositions may occur in the future. To the extent that investment dispositions exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any investment dispositions in new investments. To the extent that new investment requirements exceed our available cash on-hand, we expect to borrow under our unsecured revolving credit facility and commercial paper program. At June 30, 2023, we had $2,203,788,000 of cash and cash equivalents, $95,281,000 of restricted cash and $4,000,000,000 of available borrowing capacity under our unsecured revolving credit facility.
Key Transactions
Capital The following summarizes key capital transactions that occurred during the six months ended June 30, 2023:
In May 2023, Welltower and Welltower OP entered into the ATM Program (as defined below) pursuant to which we may offer and sell up to $2,532,139,425 of common stock of Welltower from time to time. During the six months ended June 30, 2023, we sold 17,435,154 shares of common stock under our current and previous ATM Programs generating gross proceeds of approximately $1,340,727,000.
During the six months ended June 30, 2023, we issued $373,462,000 of secured debt at a blended average interest rate of 5.05% and assumed $73,671,000 of secured debt at a blended average interest rate of 3.60%. We extinguished $72,496,000 of secured debt at a blended average interest rate of 3.99%.
In May 2023, we issued $1,035,000,000 aggregate principal amount of 2.75% exchangeable senior unsecured notes maturing May 15, 2028 unless earlier exchanged, purchased or redeemed.

30

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Investments The following summarizes our property acquisitions and joint venture investments completed during the six months ended June 30, 2023 (dollars in thousands): 
 Properties
Book Amount (1)
Capitalization Rates (2)
Seniors Housing Operating3$55,568 3.5 %
Triple-net81,659 7.5 %
Outpatient Medical29 356,734 6.9 %
Totals40 $493,961 6.6 %
(1) Represents amounts recorded in net real estate investments including fair value adjustments pursuant to U.S. GAAP. See Note 3 to our unaudited consolidated financial statements for additional information.
(2) Represents annualized contractual or projected net operating income to be received in cash divided by investment amounts.
Dispositions The following summarizes property dispositions completed during the six months ended June 30, 2023 (dollars in thousands): 
 Properties
Proceeds (1)
Book Amount (2)
Capitalization Rates (3)
Seniors Housing Operating5$241,075 $243,695 3.4 %
Triple-net12,603 2,028 — %
Totals$243,678 $245,723 3.4 %
(1) Represents net proceeds received upon disposition, including non-cash consideration.
(2) Represents carrying value of net real estate assets at time of disposition. See Note 5 to our unaudited consolidated financial statements for additional information.
(3) Represents annualized contractual income that was being received in cash at date of disposition divided by stated purchase price. Excludes properties sold that were recent development conversions.
Strategic Dissolution of Revera Joint Ventures
During the three months ended June 30, 2023, we entered into definitive agreements to dissolve our existing Revera joint venture relationships across the U.S., U.K. and Canada. The transactions include acquiring the remaining interests in 110 properties from Revera while simultaneously selling interests in 31 properties to Revera. See Note 5 to our unaudited consolidated financial statements for additional information regarding the transaction.
Dividends Our Board of Directors declared a cash dividend for the quarter ended June 30, 2023 of $0.61 per share. On August 23, 2023, we will pay our 209th consecutive quarterly cash dividend to stockholders of record on August 15, 2023.
Key Performance Indicators, Trends and Uncertainties
We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, credit strength and concentration risk. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.
Operating Performance We believe that net income and net income attributable to common stockholders (“NICS”) per the Consolidated Statements of Comprehensive Income are the most appropriate earnings measures. Other useful supplemental measures of our operating performance include funds from operations attributable to common stockholders (“FFO”) and consolidated net operating income (“NOI”); however, these supplemental measures are not defined by U.S. generally accepted accounting principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations. These earnings measures are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies.
The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands):
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
 202320232022202220222022
Net income (loss)$106,342 $28,635 $1,798 $(2,653)$95,672 $65,751 
NICS103,040 25,673 (3,728)(6,767)89,784 61,925 
FFO466,182 386,062 357,985 362,863 409,588 347,635 
NOI706,806 602,976 579,693 561,664 618,453 542,035 

31

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Credit Strength We measure our credit strength both in terms of leverage ratios and coverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt, net of cash and restricted cash. The coverage ratios indicate our ability to service interest and fixed charges (interest and secured debt principal amortization). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain a capital structure consistent with our current profile. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliation of these measures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented: 
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
 202320232022202220222022
Net debt to book capitalization ratio38%40%39%42%43%43%
Net debt to undepreciated book capitalization ratio31%32%32%34%35%35%
Net debt to market capitalization ratio25%28%30%32%27%24%
Interest coverage ratio3.81x3.44x3.29x3.48x4.21x4.03x
Fixed charge coverage ratio3.51x3.13x3.01x3.18x3.78x3.57x
Concentration Risk We evaluate our concentration risk in terms of NOI by property mix, relationship mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our NOI could be at risk if certain sectors were to experience downturns. Property mix measures the portion of our NOI that relates to our various property types. Relationship mix measures the portion of our NOI that relates to our current top five relationships. Geographic mix measures the portion of our NOI that relates to our current top five states (or international equivalents).
The following table reflects our recent historical trends of concentration risk by NOI for the periods indicated below: 
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
 202320232022202220222022
Property mix:(1)
    
Seniors Housing Operating40%42%40%41%45%38%
Triple-net42%37%38%38%36%41%
Outpatient Medical18%21%22%21%19%21%
Relationship mix: (1)
 
Integra Healthcare Properties(2)
8%9%1%—%—%—%
Sunrise Senior Living7%6%7%7%8%6%
Cogir Management Corporation3%4%4%4%3%2%
StoryPoint Senior Living3%4%3%4%3%4%
HC-One Group3%3%3%4%4%4%
Remaining relationships76%74%82%81%82%84%
Geographic mix:(1)
 
California11%13%14%13%15%13%
United Kingdom8%10%9%10%9%11%
Texas7%8%8%8%7%8%
Canada5%6%6%6%5%5%
Pennsylvania5%6%5%5%4%5%
Remaining geographic areas64%57%58%58%60%58%
(1) Excludes our share of investments in unconsolidated entities and non-segment/corporate NOI. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount.
(2) In December 2022, we transitioned 147 skilled nursing facilities previously leased to ProMedica to master leases with Integra Healthcare Properties.








32

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Lease Expirations The following table sets forth information regarding lease expirations for certain portions of our portfolio as of June 30, 2023 (dollars in thousands):
 
Expiration Year (1)
 2023202420252026202720282029203020312032Thereafter
Triple-net:          
Properties15 10 34 127 345 
Base rent (2)
$2,159 $13,088 $7,083 $12,884 $1,211 $5,246 $1,004 $69,306 $10,701 $98,438 $425,979 
% of base rent0.3 %2.0 %1.1 %2.0 %0.2 %0.8 %0.2 %10.7 %1.7 %15.2 %65.8 %
Units/beds357 692 451 1,557 80 440 219 3,669 423 6,163 37,443 
% of Units/beds0.7 %1.3 %0.9 %3.0 %0.2 %0.9 %0.4 %7.1 %0.8 %12.0 %72.7 %
Outpatient Medical:          
Square feet1,524,136 1,948,219 1,438,832 1,581,742 1,494,889 1,276,486 1,179,026 1,293,894 1,648,968 1,348,584 4,096,705 
Base rent (2)
$42,342 $58,974 $41,798 $43,360 $41,462 $34,199 $32,859 $34,890 $45,482 $38,725 $114,498 
% of base rent8.0 %11.2 %7.9 %8.2 %7.8 %6.5 %6.2 %6.6 %8.6 %7.3 %21.7 %
Leases351 344 264 244 221 203 113 101 69 139 175 
% of Leases15.8 %15.5 %11.9 %11.0 %9.9 %9.1 %5.1 %4.5 %3.1 %6.3 %7.8 %
(1) Excludes our share of investments in unconsolidated entities, developments, land parcels, loans receivable and sub-leases. Investments classified as held for sale are included in the current year.
(2) The most recent monthly cash base rent annualized. Base rent does not include tenant recoveries or amortization of above and below market lease intangibles or other non-cash income.
We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved, and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Cautionary Statement Regarding Forward-Looking Statements” and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2022, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”
Corporate Governance
Maintaining investor confidence and trust is important in today’s business environment. Our Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on the Internet at www.welltower.com/investors/governance. The information on our website is not incorporated by reference in this Quarterly Report on Form 10-Q, and our web address is included as an inactive textual reference only.
Liquidity and Capital Resources
Sources and Uses of Cash
Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses, general and administrative expenses and other expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below. 






33

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our sources and uses of cash flows for the periods presented (dollars in thousands):
 Six Months EndedChange
June 30, 2023June 30, 2022$%
Cash, cash equivalents and restricted cash at beginning of period$722,292 $346,755 $375,537 108 %
Cash provided from (used in) operating activities792,303 719,331 72,972 10 %
Cash provided from (used in) investing activities(1,326,216)(2,085,261)759,045 36 %
Cash provided from (used in) financing activities2,102,311 1,473,616 628,695 43 %
Effect of foreign currency translation8,379 (12,190)20,569 169 %
Cash, cash equivalents and restricted cash at end of period$2,299,069 $442,251 $1,856,818 420 %
Operating Activities Please see “Results of Operations” for discussion of net income fluctuations. For the six months ended June 30, 2023 and 2022, cash flows provided from operations exceeded cash distributions to stockholders. 
Investing Activities The changes in net cash provided from/used in investing activities are primarily attributable to net changes in real property investments and dispositions, loans receivable and investments in unconsolidated entities, which are summarized above in "Key Transactions." Please refer to Notes 3 and 5 of our unaudited consolidated financial statements for additional information. The following is a summary of cash used in non-acquisition capital improvement activities for the periods presented (dollars in thousands): 
 Six Months EndedChange
 June 30, 2023June 30, 2022$%
New development$474,115 $286,427 $187,688 66 %
Recurring capital expenditures, tenant improvements and lease commissions77,608 72,103 5,505 %
Renovations, redevelopments and other capital improvements127,370 127,966 (596)— %
Total$679,093 $486,496 $192,597 40 %
The change in new development is primarily due to the number and size of construction projects on-going during the relevant periods. Renovations, redevelopments and other capital improvements include expenditures to maximize property value, increase net operating income, maintain a market-competitive position and/or achieve property stabilization.
Financing Activities The changes in net cash provided from/used in financing activities are primarily attributable to changes related to our long-term debt arrangements, the issuances of common stock and dividend payments which are summarized above in "Key Transactions." Please refer to Notes 10, 11 and 14 to our unaudited consolidated financial statements for additional information.
In April 2022, we closed on an amended $5,200,000,000 unsecured credit facility, increasing our term loan capacity by $500,000,000. In May 2023, we issued $1,035,000,000 aggregate principal amount of 2.75% exchangeable senior unsecured notes maturing May 15, 2028. During the six months ended June 30, 2023, we issued $373,462,000 of secured debt at a blended average interest rate of 5.05% and assumed $73,671,000 of secured debt at a blended average interest rate of 3.60%. As of June 30, 2023, we have total near-term available liquidity of approximately $6.3 billion.
Off-Balance Sheet Arrangements 
At June 30, 2023, we had investments in unconsolidated entities with our ownership generally ranging from 10% to 95%. We use financial derivative instruments to hedge interest rate and foreign currency exchange rate exposure. At June 30, 2023, we had 24 outstanding letter of credit obligations. Please see Notes 8, 12 and 13 to our unaudited consolidated financial statements for additional information.






34

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Contractual Obligations
The following table summarizes our payment requirements under contractual obligations as of June 30, 2023 (in thousands):
 Payments Due by Period
Contractual ObligationsTotal20232024-20252026-2027Thereafter
Senior unsecured notes and term credit facilities: (1)
U.S. Dollar senior unsecured notes$10,935,000 $— $2,600,000 $1,200,000 $7,135,000 
Canadian Dollar senior unsecured notes (2)
226,723 — — 226,723 — 
Pounds Sterling senior unsecured notes (2)
1,334,445 — — — 1,334,445 
U.S. Dollar term credit facility1,010,000 — 10,000 1,000,000 — 
Canadian Dollar term credit facility (2)
188,936 — — 188,936 — 
Secured debt: (1,2)
Consolidated2,496,591 398,560 769,001 334,500 994,530 
Unconsolidated1,332,868 216,141 713,839 202,880 200,008 
Contractual interest obligations: (3)
Senior unsecured notes and term loans (2)
4,105,949 479,272 990,010 796,673 1,839,994 
Consolidated secured debt (2)
503,505 52,782 153,731 112,721 184,271 
Unconsolidated secured debt (2)
167,858 30,053 68,731 23,096 45,978 
Financing lease liabilities (4)
149,086 2,393 6,117 4,098 136,478 
Operating lease liabilities (4)
953,395 9,672 34,528 31,411 877,784 
Purchase obligations (5)
2,037,326 901,528 1,042,867 67,781 25,150 
Total contractual obligations$25,441,682 $2,090,401 $6,388,824 $4,188,819 $12,773,638 
(1) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(2) Based on foreign currency exchange rates in effect as of the balance sheet date.
(3) Based on variable interest rates in effect as of the balance sheet date.
(4) See Note 6 to our unaudited consolidated financial statements for additional information.
(5) See Note 13 to our unaudited consolidated financial statements for additional information.
Capital Structure
Please refer to “Credit Strength” above for a discussion of our leverage and coverage ratio trends. Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2023, we were in compliance in all material respects with the covenants under our debt agreements. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our primary unsecured credit facility, the ratings on our senior unsecured notes are used to determine the fees and interest charged. We plan to manage the company to maintain compliance with our debt covenants and with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the rating agencies could have a material adverse impact on our cost and availability of capital, which could have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.
On April 1, 2022, Welltower and Welltower OP jointly filed with the Securities and Exchange Commission (the “SEC”) an open-ended automatic or “universal” shelf registration statement on Form S-3 (the "Shelf Form S-3") covering an indeterminate amount of future offerings of Welltower’s debt securities, common stock, preferred stock, depositary shares, guarantees of debt securities issued by Welltower OP, warrants and units and Welltower OP’s debt securities and guarantees of debt securities issued by Welltower to replace Old Welltower’s existing “universal” shelf registration statement filed with the SEC on May 4, 2021. On May 3, 2023, Welltower and Welltower OP filed post-effective amendment no. 1 to the Shelf Form S-3 pursuant to which Welltower OP expressly adopted the Shelf Form S-3 as its own registration statement following its statutory conversion from a corporation to a limited liability company. On April 1, 2022, Welltower also filed with the SEC a registration statement in connection with its enhanced dividend reinvestment plan (“DRIP”) under which it may issue up to 15,000,000 shares of common stock to replace Old Welltower’s existing DRIP registration statement on Form S-3 filed with the SEC on May 4, 2021. As of July 28, 2023, 15,000,000 shares of common stock remained available for issuance under the DRIP registration statement. On May 3, 2023, Welltower and Welltower OP entered into an equity distribution agreement (the “EDA”) with (i) Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BMO Capital Markets Corp., BNP Paribas Securities Corp., BNY Mellon Capital Markets, LLC, BofA Securities, Inc., BOK Financial Securities, Inc., Capital One Securities Inc., Citigroup Global Markets Inc., Comerica Securities, Inc., Credit Agricole Securities (USA) Inc., Deutsche Bank Securities Inc., Fifth Third Securities, Inc., Goldman Sachs & Co. LLC, Jefferies LLC, JMP Securities LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Loop Capital Markets LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, Regions Securities LLC, Scotia Capital (USA) Inc., Synovus Securities, Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC as sales agents and forward sellers and (ii) the
35

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
forward purchasers named therein relating to issuances, offers and sales from time to time of up to $2,532,139,425 aggregate amount of common stock of Welltower (together with the existing master forward sale confirmations relating thereto, the “ATM Program”). The ATM Program also allows Welltower to enter into forward sale agreements. As of July 28, 2023, we had $832,381,771 of remaining capacity under the ATM Program and there were no outstanding forward sales agreements. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our unsecured revolving credit facility and commercial paper program.
In connection with the filing of the Shelf Form S-3, Welltower also filed with the SEC a prospectus supplement that will continue an offering that was previously covered by Old Welltower's prospectus supplement and the accompanying prospectus to the prior registration statement relating to the registration of up to 475,327 shares of common stock of Welltower Inc. (the “DownREIT II Shares”) that may be issued from time to time if, and to the extent that, certain holders of Class A units (the “DownREIT II Units”) of HCN G&L DownREIT II LLC, a Delaware limited liability company (the “DownREIT II”), tender such DownREIT II Units for redemption by the DownREIT II, and HCN DownREIT Member, LLC, a majority-owned indirect subsidiary of Welltower (including its permitted successors and assigns, the “Managing Member”), or a designated affiliate of the Managing Member, elects to assume the redemption obligations of the DownREIT II and to satisfy all or a portion of the redemption consideration by issuing DownREIT II Shares to the holders instead of or in addition to paying a cash amount. On July 22, 2022, Welltower filed with the SEC a prospectus supplement relating to the registration of up to 300,026 shares of common stock of Welltower Inc. that may be issued from time to time if, and to the extent that, certain holders of Class A Common Units (the "OP Units") of Welltower OP tender the OP Units for redemption by Welltower OP, and Welltower Inc. elects to assume the redemption obligations of Welltower OP and to satisfy all or a portion of the redemption consideration by issuing shares of its common stock to the holders instead of or in addition to paying a cash amount.
Supplemental Guarantor Information
Welltower OP has issued the unsecured notes described in Note 11 to our unaudited consolidated financial statements. All unsecured notes are fully and unconditionally guaranteed by Welltower, and Welltower OP is 99.727% owned by Welltower as of June 30, 2023. Effective January 4, 2021, the SEC adopted amendments to the financial disclosure requirements applicable to registered debt offerings that include certain credit enhancements. We have adopted these new rules, which permits subsidiary issuers of obligations guaranteed by the parent to omit separate financial statements if the consolidated financial statements of the parent company have been filed, the subsidiary obligor is a consolidated subsidiary of the parent company, the guaranteed security is debt or debt-like, and the security is guaranteed fully and unconditionally by the parent. Accordingly, separate consolidated financial statements of Welltower OP have not been presented. Furthermore, Welltower and Welltower OP have no material assets, liabilities, or operations other than financing activities and their investments in non-guarantor subsidiaries. Therefore, we meet the criteria in Rule 13-01 of Regulation S-X to omit the summarized financial information from our disclosures.
Results of Operations
Summary
Our primary sources of revenue include resident fees and services, rent and interest income. Our primary expenses include property operating expenses, depreciation and amortization, interest expense, general and administrative expenses and other expenses. We evaluate our business and make resource allocations on our three business segments: Seniors Housing Operating, Triple-net and Outpatient Medical. The primary performance measures for our properties are NOI and same store NOI ("SSNOI"), and other supplemental measures include Funds From Operations ("FFO") and EBITDA, which are further discussed below. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations. The following is a summary of our results of operations (dollars in thousands, except per share amounts):
 Three Months EndedChangeSix Months EndedChange
 June 30,June 30,  June 30,June 30,
 20232022Amount%20232022Amount%
Net income (loss)$106,342 $95,672 $10,670 11 %$134,977 $161,423 $(26,446)(16)%
NICS103,040 89,784 13,256 15 %128,713 151,709 (22,996)(15)%
FFO466,182 409,588 56,594 14 %852,244 757,223 95,021 13 %
EBITDA604,127 536,782 67,345 13 %1,119,322 1,033,330 85,992 %
NOI706,806 618,453 88,353 14 %1,309,782 1,160,488 149,294 13 %
SSNOI447,575 405,829 41,746 10 %856,241 780,365 75,876 10 %
Per share data (fully diluted):    
NICS$0.20 $0.20 $— — %$0.26 $0.33 $(0.07)(21)%
FFO$0.93 $0.90 $0.03 %$1.71 $1.67 $0.04 %
Interest coverage ratio3.81 x4.21 x(0.40)x(10)%3.63 x4.12 x(0.49)x(12)%
Fixed charge coverage ratio3.51 x3.78 x(0.27)x(7)%3.32 x3.68 x(0.36)x(10)%
36

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Seniors Housing Operating
The following is a summary of our results of operations for the Seniors Housing Operating segment (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,June 30,  June 30,June 30,
 20232022$%20232022$%
Revenues:    
Resident fees and services$1,159,449 $1,009,999 $149,450 15 %$2,291,134 $2,004,334 $286,800 14 %
Interest income2,095 1,683 412 24 %4,646 3,100 1,546 50 %
Other income2,895 59,528 (56,633)(95)%5,340 60,388 (55,048)(91)%
Total revenues1,164,439 1,071,210 93,229 %2,301,120 2,067,822 233,298 11 %
Property operating expenses885,187 789,299 95,888 12 %1,768,971 1,579,227 189,744 12 %
NOI (1)
279,252 281,911 (2,659)(1)%532,149 488,595 43,554 %
Other expenses:  
Depreciation and amortization220,428 201,178 19,250 10 %440,835 393,971 46,864 12 %
Interest expense16,136 7,481 8,655 116 %27,623 15,131 12,492 83 %
Loss (gain) on extinguishment of debt, net— 400 (400)(100)%— 385 (385)(100)%
Provision for loan losses, net1,867 342 1,525 446 %1,794 609 1,185 195 %
Impairment of assets— — — n/a12,629 — 12,629 n/a
Other expenses8,060 29,249 (21,189)(72)%25,639 37,440 (11,801)(32)%
246,491 238,650 7,841 %508,520 447,536 60,984 14 %
Income (loss) from continuing operations before income taxes and other items32,761 43,261 (10,500)(24)%23,629 41,059 (17,430)(42)%
Income (loss) from unconsolidated entities(39,445)(12,669)(26,776)(211)%(55,034)(30,451)(24,583)(81)%
Gain (loss) on real estate dispositions, net(2,096)(1,224)(872)(71)%(1,263)1,477 (2,740)(186)%
Income from continuing operations(8,780)29,368 (38,148)(130)%(32,668)12,085 (44,753)(370)%
Net income (loss)(8,780)29,368 (38,148)(130)%(32,668)12,085 (44,753)(370)%
Less: Net income (loss) attributable to noncontrolling interests(2,872)(2,857)(15)(1)%(6,189)(8,238)2,049 25 %
Net income (loss) attributable to common stockholders$(5,908)$32,225 $(38,133)(118)%$(26,479)$20,323 $(46,802)(230)%
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Resident fees and services and property operating expenses increased for the three and six month periods ended June 30, 2023 compared to the same periods in the prior year primarily due to acquisitions outpacing dispositions during 2022 and year to date 2023. Additionally, our Seniors Housing Operating revenues are dependent on occupancy and rate growth, both of which have continued to increase since the same period in the prior year. Average occupancy is as follows:
Three Months Ended(1)
 March 31,June 30,September 30,December 31,
202276.3 %77.1 %78.0 %78.3 %
202379.0 %79.6 %
(1) Average occupancy includes our minority ownership share related to unconsolidated properties and excludes the minority partners' noncontrolling ownership share related to consolidated properties. Also excludes land parcels and properties under development.
Effective on April 1, 2022, our leasehold interest relating to the master lease with National Health Investors, Inc. ("NHI") for 17 properties assumed in conjunction with the Holiday Retirement acquisition was terminated as a result of the transition or sale of the properties by NHI. The lease termination was part of an agreement to resolve outstanding litigation with NHI. In conjunction with the agreement, a wholly-owned subsidiary and the lessee on the master lease agreed to release $6,883,000 of cash to the landlord, which represents the net cash flow generated from the properties since we assumed the leasehold interest. Additionally, in connection with the lease termination, during the three months ended June 30, 2022, we recognized $58,621,000 in other income on our Consolidated Statements of Comprehensive Income from the derecognition of the right of use asset and related lease liability.



37

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our SSNOI at Welltower's share for the Seniors Housing Operating segment (dollars in thousands):
QTD PoolYTD Pool
 Three Months EndedChangeSix Months EndedChange
 June 30, 2023June 30, 2022$%June 30, 2023June 30, 2022$%
SSNOI (1)
$221,605 $186,931 $34,674 18.5 %$409,387 $343,464 $65,923 19.2 %
(1) For the QTD Pool and YTD Pool, amounts relate to 674 and 661 same store properties, respectively. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
During the six months ended June 30, 2023, we recorded impairment charges of $12,252,000 related to two held for sale properties for which the carrying values exceeded the estimated fair value less costs to sell and $377,000 related to one held for use property for which the carrying value exceeded the estimated fair value. No impairment was recorded during the same period in 2022. Transaction costs related to asset acquisitions are capitalized as a component of the purchase price. The fluctuation in other expenses is primarily due to the timing of noncapitalizable transaction costs associated with acquisitions and operator transitions. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices.
Depreciation and amortization fluctuates as a result of acquisitions, dispositions and transitions. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. 
During the six months ended June 30, 2023, we completed five conversions representing $140,865,000 or $229,796 per unit. The following is a summary of our Seniors Housing Operating construction projects in process, excluding expansions (dollars in thousands):
As of June 30, 2023
Expected Conversion Year(1)
PropertiesUnits/BedsAnticipated Remaining FundingConstruction in Progress Balance
20235853 $50,705 $196,623 
2024162,626 478,984 496,374 
20251409 64,449 21,939 
TBD(2)
13125,633 
Total35$840,569 
(1) Properties expected to be converted in phases over multiple years are reflected in the last expected year.
(2) Represents projects for which a final budget or expected conversion date are not yet known.
Interest expense represents secured debt interest expense, which fluctuates based on the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The fluctuations in loss (gain) on extinguishment of debt is primarily attributable to the volume of extinguishments and terms of the related secured debt.
The following is a summary of our Seniors Housing Operating segment property secured debt principal activity (dollars in thousands):
 Three Months EndedSix Months Ended
 June 30, 2023June 30, 2022June 30, 2023June 30, 2022
 AmountWeighted Average Interest RateAmountWeighted Average Interest RateAmountWeighted Average Interest RateAmountWeighted Average Interest Rate
Beginning balance$2,058,618 4.58 %$1,554,473 2.83 %$1,701,939 4.32 %$1,599,522 2.81 %
Debt transferred— — %— — %— — %32,478 4.79 %
Debt issued10,562 7.62 %4,959 3.40 %373,462 5.05 %10,344 3.23 %
Debt assumed20,448 3.53 %221,159 4.32 %26,930 3.70 %221,159 4.32 %
Debt extinguished(3,315)4.02 %(60,916)4.26 %(3,315)4.02 %(155,563)4.23 %
Principal payments(11,997)3.71 %(11,515)3.11 %(25,004)3.84 %(24,513)3.03 %
Foreign currency20,477 4.08 %(31,068)3.01 %20,781 4.07 %(6,335)2.97 %
Ending balance$2,094,793 4.71 %$1,677,092 3.34 %$2,094,793 4.71 %$1,677,092 3.34 %
Monthly averages$2,081,643 4.62 %$1,605,163 2.92 %$1,952,094 4.54 %$1,605,943 2.88 %
38

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The majority of our Seniors Housing Operating properties are formed through partnership interests. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Income from unconsolidated entities during the six months ended June 30, 2023 includes an impairment charge of $27,708,000 related to an unconsolidated management company. Net income attributable to noncontrolling interests represents our partners’ share of net income (loss) related to joint ventures.
Triple-net
The following is a summary of our results of operations for the Triple-net segment (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,June 30,  June 30,June 30,
 20232022$%20232022$%
Revenues:    
Rental income$198,916 $197,182 $1,734 %$401,335 $393,183 $8,152 %
Interest income36,520 35,392 1,128 %70,283 72,898 (2,615)(4)%
Other income66,692 1,786 64,906 n/a68,575 3,442 65,133 n/a
Total revenues302,128 234,360 67,768 29 %540,193 469,523 70,670 15 %
Property operating expenses10,598 11,491 (893)(8)%22,321 22,702 (381)(2)%
NOI (1)
291,530 222,869 68,661 31 %517,872 446,821 71,051 16 %
Other expenses:    
Depreciation and amortization55,234 49,561 5,673 11 %109,762 103,065 6,697 %
Interest expense(795)320 (1,115)(348)%(810)634 (1,444)(228)%
Loss (gain) on derivatives and financial instruments, net1,280 (1,407)2,687 191 %2,210 1,171 1,039 89 %
Provision for loan losses, net591 (176)767 436 %1,441 (1,241)2,682 216 %
Impairment of assets1,086 — 1,086 n/a1,086 — 1,086 n/a
Other expenses818 463 355 77 %3,285 11,507 (8,222)(71)%
58,214 48,761 9,453 19 %116,974 115,136 1,838 %
Income (loss) from continuing operations before income taxes and other items233,316 174,108 59,208 34 %400,898 331,685 69,213 21 %
Income (loss) from unconsolidated entities(630)5,874 (6,504)(111)%7,802 21,417 (13,615)(64)%
Gain (loss) on real estate dispositions, net(72)(2,129)2,057 97 %448 18,320 (17,872)(98)%
Income from continuing operations232,614 177,853 54,761 31 %409,148 371,422 37,726 10 %
Net income232,614 177,853 54,761 31 %409,148 371,422 37,726 10 %
Less: Net income (loss) attributable to noncontrolling interests6,187 7,241 (1,054)(15)%12,090 14,306 (2,216)(15)%
Net income attributable to common stockholders$226,427 $170,612 $55,815 33 %$397,058 $357,116 $39,942 11 %
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase. For the three months ended June 30, 2023, we had 26 leases with rental rate increases ranging from 0.72% to 68.87% in our Triple-net portfolio.
As part of the substantial exit of the Genesis HealthCare operating relationship, which we disclosed on March 2, 2021, we transitioned the sublease of a portfolio of seven facilities from Genesis HealthCare to Complete Care Management in the second quarter of 2021. As part of the March 2021 transaction, we entered into a forward sale agreement for the seven properties valued at $182,618,000, which was expected to close when the Welltower-held purchase option became exercisable. As of March 31, 2023, the right of use assets related to the properties were $115,359,000 and were reflected as held for sale with the corresponding lease liabilities of $66,530,000 on our Consolidated Balance Sheet.
On May 1, 2023, we executed a series of transactions that included the assignment of the leasehold interest to a newly formed tri-party unconsolidated joint venture with Aurora Health Network, Peace Capital (an affiliate of Complete Care Management) and us, and culminated with the closing of the purchase option by the joint venture. The transactions resulted in net cash proceeds to us of $104,240,000 after our retained interest of $11,571,000 in the joint venture and a gain from the loss of control and derecognition of the leasehold interest of $65,485,000, which we recorded in other income within our Consolidated Statements of Comprehensive Income.

39

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our SSNOI at Welltower's share for the Triple-net segment (dollars in thousands):
QTD PoolYTD Pool
 Three Months EndedChangeSix Months EndedChange
 June 30, 2023June 30, 2022$%June 30, 2023June 30, 2022$%
SSNOI (1)
$113,237 $109,263 $3,974 3.6 %$225,804 $220,956 $4,848 2.2 %
(1) For the QTD Pool and YTD Pool, amounts relate to 375 same store properties. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
Depreciation and amortization fluctuates as a result of the acquisitions, dispositions and segment transitions of Triple-net properties. To the extent we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly. 
During the three months ended June 30, 2023, we recorded impairment charges of $1,086,000 related to one held for sale property. Transaction costs related to asset acquisitions are capitalized as a component of purchase price. The fluctuation in other expenses is primarily due to noncapitalizable transaction costs from acquisitions and segment transitions. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices.
During the six months ended June 30, 2023, there was one Triple-net construction project completed representing $141,142,000 or $738,963 per unit.

Interest expense represents secured debt interest expense and related fees. The change in secured debt interest expense is due to the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The following is a summary of our Triple-net secured debt principal activity for the periods presented (dollars in thousands):
 Three Months EndedSix Months Ended
 June 30, 2023June 30, 2022June 30, 2023June 30, 2022
 AmountWeighted Average Interest RateAmountWeighted Average Interest RateAmountWeighted Average Interest RateAmountWeighted Average Interest Rate
Beginning balance$38,949 4.39 %$39,837 4.39 %$39,179 4.39 %$72,536 4.57 %
Debt transferred— — %— — %— — %(32,478)4.79 %
Principal payments(226)4.37 %(215)4.37 %(456)4.37 %(436)4.37 %
Ending balance$38,723 4.39 %$39,622 4.39 %$38,723 4.39 %$39,622 4.39 %
Monthly averages$38,798 4.39 %$39,693 4.39 %$38,914 4.39 %$39,804 4.39 %
A portion of our Triple-net properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. The decrease in income from unconsolidated entities during the three and six month periods is primarily related to the restructure of an unconsolidated joint venture into a consolidated structure. Net income attributable to noncontrolling interests represents our partners’ share of net income relating to those partnerships where we are the controlling partner.









40

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Outpatient Medical
The following is a summary of our results of operations for the Outpatient Medical segment for the periods presented (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,June 30,  June 30,June 30,
 20232022$%20232022$%
Revenues:    
Rental income$184,523 $164,229 $20,294 12 %$366,163 $324,618 $41,545 13 %
Interest income95 65 30 46 %186 136 50 37 %
Other income1,574 2,028 (454)(22)%4,674 4,891 (217)(4)%
Total revenues186,192 166,322 19,870 12 %371,023 329,645 41,378 13 %
Property operating expenses58,697 50,648 8,049 16 %117,062 100,563 16,499 16 %
NOI (1)
127,495 115,674 11,821 10 %253,961 229,082 24,879 11 %
Other expenses:    
Depreciation and amortization66,283 59,556 6,727 11 %130,460 117,347 13,113 11 %
Interest expense3,152 4,531 (1,379)(30)%7,256 9,098 (1,842)(20)%
Loss (gain) on extinguishment of debt, net(3)(75)%(1)(14)%
Provision for loan losses, net(2)(1)(1)(100)%(2)(7)71 %
Other expenses647 207 440 213 %1,194 996 198 20 %
70,081 64,297 5,784 %138,914 127,441 11,473 %
Income (loss) from continuing operations before income taxes and other items57,414 51,377 6,037 12 %115,047 101,641 13,406 13 %
Income (loss) from unconsolidated entities(257)(263)%(171)(908)737 81 %
Gain (loss) on real estate dispositions, net— (179)179 100 %(606)(395)(211)(53)%
Income from continuing operations57,157 50,935 6,222 12 %114,270 100,338 13,932 14 %
Net income (loss)57,157 50,935 6,222 12 %114,270 100,338 13,932 14 %
Less: Net income (loss) attributable to noncontrolling interests309 1,498 (1,189)(79)%991 3,640 (2,649)(73)%
Net income (loss) attributable to common stockholders$56,848 $49,437 $7,411 15 %$113,279 $96,698 $16,581 17 %
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
Rental income has increased due primarily to acquisitions and construction conversions that occurred during 2022 and the year to date in 2023. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Our leases could renew above or below current rental rates, resulting in an increase or decrease in rental income. For the three months ended June 30, 2023, our consolidated outpatient medical portfolio signed 167,629 square feet of new leases and 308,781 square feet of renewals. The weighted-average term of these leases was seven years, with a rate of $34.36 per square foot and tenant improvement and lease commission costs of $28.75 per square foot. Substantially all of these leases contain an annual fixed or contingent escalation rent structure ranging from 1.5% to 28.0%. 
The fluctuations in property operating expenses and depreciation and amortization are primarily attributable to acquisitions and construction conversions that occurred during 2022 and year to date in 2023. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly.
The following is a summary of our SSNOI at Welltower's share for the Outpatient Medical segment (dollars in thousands):
QTD PoolYTD Pool
 Three Months EndedChangeSix Months EndedChange
 June 30, 2023June 30, 2022$%June 30, 2023June 30, 2022$%
SSNOI (1)
$112,733 $109,635 $3,098 2.8 %$221,050 $215,945 $5,105 2.4 %
(1) For the QTD Pool and YTD Pool, amounts relate to 374 and 370 same store properties, respectively. Please see "Non-GAAP Financial Measures" below for additional information and reconciliations.
During the six months ended June 30, 2023, we completed two conversions representing $21,173,000 or $425 per square foot. The following is a summary of the consolidated Outpatient Medical construction projects in process, excluding expansions (dollars in thousands):
41

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
As of June 30, 2023
Expected Conversion YearPropertiesSquare FeetAnticipated Remaining FundingConstruction in Progress Balance
20232195,276 $58,360 $58,555 
20244279,332 97,156 43,332 
TBD(1)
236,996 
Total8$138,883 
(1) Represents projects for which a final budget or expected conversion date are not yet known.
Total interest expense represents secured debt interest expense. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. The following is a summary of our Outpatient Medical secured debt principal activity (dollars in thousands):
 Three Months EndedSix Months Ended
 June 30, 2023June 30, 2022June 30, 2023June 30, 2022
 AmountWeighted Average Interest RateAmountWeighted Average Interest RateAmountWeighted Average Interest RateAmountWeighted Average Interest Rate
Beginning balance$409,241 4.43 %$521,331 3.51 %$388,836 4.38 %$530,254 3.49 %
Debt assumed— — %— — %46,741 3.54 %— — %
Debt extinguished(44,550)3.69 %(34,767)3.79 %(69,181)3.99 %(40,941)3.84 %
Principal payments(1,616)4.30 %(2,652)4.37 %(3,321)4.29 %(5,401)4.39 %
Ending balance$363,075 4.68 %$483,912 3.68 %$363,075 4.68 %$483,912 3.68 %
Monthly averages$386,125 4.57 %$507,966 3.64 %$397,993 4.49 %$517,179 3.57 %
A portion of our Outpatient Medical properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income or loss relating to those partnerships where we are the controlling partner.
Non-Segment/Corporate
The following is a summary of our results of operations for the Non-Segment/Corporate activities for the periods presented (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,June 30,  June 30,June 30,
 20232022$%20232022$%
Revenues:    
Other income$12,719 $644 $12,075 n/a$13,871 $1,250 $12,621 n/a
Total revenues12,719 644 12,075 n/a13,871 1,250 12,621 n/a
Property operating expenses4,190 2,645 1,545 58 %8,071 5,260 2,811 53 %
Consolidated net operating income (loss) (1)
8,529 (2,001)10,530 526 %5,800 (4,010)9,810 245 %
Expenses:   
Interest expense133,844 115,418 18,426 16 %262,671 224,583 38,088 17 %
General and administrative expenses44,287 36,554 7,733 21 %88,658 74,260 14,398 19 %
Loss (gain) on extinguishment of debt, net— 199 (199)(100)%— 199 (199)(100)%
Other expenses1,544 5,247 (3,703)(71)%3,696 11,292 (7,596)(67)%
179,675 157,418 22,257 14 %355,025 310,334 44,691 14 %
Loss from continuing operations before income taxes and other items(171,146)(159,419)(11,727)(7)%(349,225)(314,344)(34,881)(11)%
Income tax benefit (expense)(3,503)(3,065)(438)(14)%(6,548)(8,078)1,530 19 %
Loss from continuing operations(174,649)(162,484)(12,165)(7)%(355,773)(322,422)(33,351)(10)%
Net loss attributable to common stockholders$(174,649)$(162,484)$(12,165)(7)%$(355,773)$(322,422)$(33,351)(10)%
(1) See "Non-GAAP Financial Measures" below for additional information and reconciliations.
42

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The increase in other income for the three and six month periods ended June 30, 2023 is primarily due to interest earned on deposits. Property operating expenses represent insurance costs related to our captive insurance company, which acts as a direct insurer of property level insurance coverage for our portfolio.
The following is a summary of our Non-Segment/Corporate interest expense for the periods presented (dollars in thousands):
 Three Months EndedChangeSix Months EndedChange
 June 30,June 30,  June 30,June 30,  
 20232022$%20232022$%
Senior unsecured notes$125,451 $106,431 $19,020 18 %$246,265 $207,670 $38,595 19 %
Unsecured credit facility and commercial paper program1,467 4,088 (2,621)(64)%3,873 6,866 (2,993)(44)%
Loan expense6,926 4,899 2,027 41 %12,533 10,047 2,486 25 %
Totals$133,844 $115,418 $18,426 16 %$262,671 $224,583 $38,088 17 %
The change in interest expense on senior unsecured notes is due to the net effect of issuances and extinguishments, as well as the movement in foreign exchange rates and related hedge activity. Please refer to Note 11 to our unaudited consolidated financial statements for additional information. The change in interest expense on our unsecured revolving credit facility and commercial paper program is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes. Please refer to Note 10 to our unaudited consolidated financial statements for additional information regarding our unsecured revolving credit facility and commercial paper program. Loan expenses represent the amortization of costs incurred in connection with senior unsecured notes issuances.
General and administrative expenses as a percentage of consolidated revenues for the six months ended June 30, 2023 and 2022 were 2.75% and 2.59%, respectively. The provision for income taxes primarily relates to state taxes, foreign taxes and taxes based on income generated by entities that are structured as TRSs.
Other
Non-GAAP Financial Measures
We believe that net income and net income attributable to common stockholders, as defined by U.S. GAAP, are the most appropriate earnings measurements. However, we consider FFO, NOI, SSNOI, EBITDA and Adjusted EBITDA to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created funds from operations attributable to common stockholders (“FFO”) as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means NICS, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.
NOI is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our properties. These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to operators, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent general overhead costs that are unrelated to property operations and unallocable to the properties. These expenses include, but are not limited to, payroll and benefits related to corporate employees, professional services, office expenses and depreciation of corporate fixed assets. Same store NOI (“SSNOI”) is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. We believe the drivers of property level NOI for both consolidated properties and unconsolidated properties are generally the same and therefore, we evaluate SSNOI based on our ownership interest in each property ("Welltower Share"). To arrive at Welltower's Share, NOI is adjusted by adding our minority ownership share related to unconsolidated properties and by subtracting the minority partners' noncontrolling ownership interests for consolidated properties. We do not control investments in unconsolidated properties and while we consider disclosures at Welltower Share to be useful, they may not accurately depict the legal and economic implications of our joint venture arrangements and should be used with caution. As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the relevant year-over-year reporting periods. Acquisitions and development conversions are included in SSNOI five full quarters or six full quarters after acquisition or being placed into service for the QTD Pool and the YTD Pool, respectively. Land parcels, loans and sub-leases, as well as any properties sold or classified as held for sale during the respective periods are excluded from SSNOI. Redeveloped properties (including major refurbishments of a Seniors Housing Operating property where 20% or more of units are simultaneously taken out of commission for 30 days or more or Outpatient Medical properties
43

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
undergoing a change in intended use) are excluded from SSNOI until five full quarters or six full quarters post completion of the redevelopment for the QTD Pool and YTD Pool, respectively. Properties undergoing operator transitions and/or segment transitions are also excluded from SSNOI until five full quarters or six full quarters post completion of the transition for the QTD Pool and YTD Pool, respectively. In addition, properties significantly impacted by force majeure, acts of God, or other extraordinary adverse events are excluded from SSNOI until five full quarters or six full quarters after the properties are placed back into service for the QTD Pool and YTD Pool, respectively. SSNOI excludes non-cash NOI and includes adjustments to present consistent ownership percentages and to translate Canadian properties and U.K. properties using a consistent exchange rate. We believe NOI and SSNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOI and SSNOI to make decisions about resource allocations and to assess the property level performance of our properties.
EBITDA is defined as earnings (net income) before interest, taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA excluding unconsolidated entities and including adjustments for stock-based compensation expense, provision for loan losses, gains/losses on extinguishment of debt, gains/loss/impairments on properties, gains/losses on derivatives and financial instruments, other expenses, other impairment charges and other adjustments as deemed appropriate. We believe that EBITDA and Adjusted EBITDA, along with net income, are important supplemental measures because they provide additional information to assess and evaluate the performance of our operations. We primarily use these measures to determine our interest coverage ratio, which represents EBITDA and Adjusted EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA and Adjusted EBITDA divided by fixed charges. Fixed charges include total interest and secured debt principal amortization. Covenants in our unsecured senior notes and primary credit facility contain financial ratios based on a definition of EBITDA and Adjusted EBITDA that is specific to those agreements. Our leverage ratios are defined as the proportion of net debt to total capitalization and include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt, excluding operating lease liabilities, less cash and cash equivalents and restricted cash), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock.
Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.
The table below reflects the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure, for the periods presented. Noncontrolling interest and unconsolidated entity amounts represent adjustments to reflect our share of depreciation and amortization, gains/loss on real estate dispositions and impairment of assets. Amounts are in thousands except for per share data.
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
FFO Reconciliation:202320232022202220222022
Net income (loss) attributable to common stockholders$103,040 $25,673 $(3,728)$(6,767)$89,784 $61,925 
Depreciation and amortization341,945 339,112 342,286 353,699 310,295 304,088 
Impairment of assets1,086 12,629 13,146 4,356 — — 
Loss (gain) on real estate dispositions, net2,168 (747)4,423 (1,064)3,532 (22,934)
Noncontrolling interests(12,841)(13,327)(13,989)(14,614)(13,173)(14,753)
Unconsolidated entities30,784 22,722 15,847 27,253 19,150 19,309 
FFO$466,182 $386,062 $357,985 $362,863 $409,588 $347,635 
Average diluted shares outstanding
For net income (loss) purposes501,970 494,494 483,305 463,366 457,082 449,802 
For FFO purposes501,970 494,494 486,419 466,950 457,082 449,802 
Per diluted share data:    
Net income attributable to common stockholders(1)
$0.20 $0.05 $(0.01)$(0.01)$0.20 $0.14 
FFO$0.93 $0.78 $0.74 $0.78 $0.90 $0.77 
(1) Includes adjustment to the numerator for income (loss) attributable to OP Unitholders.
44

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Six Months Ended
 June 30,June 30,
FFO Reconciliations:20232022
Net income attributable to common stockholders$128,713 $151,709 
Depreciation and amortization681,057 614,383 
Impairment of assets13,715 — 
Loss (gain) on real estate dispositions, net1,421 (19,402)
Noncontrolling interests(26,168)(27,926)
Unconsolidated entities53,506 38,459 
FFO$852,244 $757,223 
Average diluted common shares outstanding:498,305 453,455
Per diluted share data:  
Net income attributable to common stockholders(1)
$0.26 $0.33 
FFO$1.71 $1.67 
(1) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.
The table below reflects the reconciliation of consolidated NOI to net income, the most directly comparable U.S. GAAP measure, for the periods presented (dollars in thousands):
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
NOI Reconciliations:202320232022202220222022
Net income (loss)$106,342 $28,635 $1,798 $(2,653)$95,672 $65,751 
Loss (gain) on real estate dispositions, net2,168 (747)4,423 (1,064)3,532 (22,934)
Loss (income) from unconsolidated entities40,332 7,071 4,650 6,698 7,058 2,884 
Income tax expense (benefit)3,503 3,045 (4,088)3,257 3,065 5,013 
Other expenses11,069 22,745 24,954 15,481 35,166 26,069 
Impairment of assets1,086 12,629 13,146 4,356 — — 
Provision for loan losses, net2,456 777 10,469 490 165 (804)
Loss (gain) on extinguishment of debt, net87 603 (12)
Loss (gain) on derivatives and financial instruments, net1,280 930 258 6,905 (1,407)2,578 
General and administrative expenses44,287 44,371 41,319 34,811 36,554 37,706 
Depreciation and amortization341,945 339,112 342,286 353,699 310,295 304,088 
Interest expense152,337 144,403 140,391 139,682 127,750 121,696 
Consolidated net operating income (NOI)$706,806 $602,976 $579,693 $561,664 $618,453 $542,035 
NOI by segment:    
Seniors Housing Operating$279,252 $252,897 $234,091 $230,686 $281,911 $206,684 
Triple-net291,530 226,342 222,879 217,324 222,869 223,952 
Outpatient Medical127,495 126,466 124,421 119,257 115,674 113,408 
Non-segment/corporate8,529 (2,729)(1,698)(5,603)(2,001)(2,009)
Total NOI$706,806 $602,976 $579,693 $561,664 $618,453 $542,035 


45

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
 Six Months Ended
June 30, 2023June 30, 2022
NOI Reconciliations:
Net income (loss)$134,977 $161,423 
Loss (gain) on real estate dispositions, net1,421 (19,402)
Loss (income) from unconsolidated entities47,403 9,942 
Income tax expense (benefit)6,548 8,078 
Other expenses33,814 61,235 
Impairment of assets13,715 — 
Provision for loan losses, net3,233 (639)
Loss (gain) on extinguishment of debt, net591 
Loss (gain) on derivatives and financial instruments, net2,210 1,171 
General and administrative expenses88,658 74,260 
Depreciation and amortization681,057 614,383 
Interest expense296,740 249,446 
Consolidated net operating income (NOI)$1,309,782 $1,160,488 
NOI by segment:
Seniors Housing Operating$532,149 $488,595 
Triple-net517,872 446,821 
Outpatient Medical253,961 229,082 
Non-segment/corporate5,800 (4,010)
Total NOI$1,309,782 $1,160,488 

The following is a reconciliation of the properties included in our QTD Pool and YTD Pool for SSNOI:
QTD PoolYTD Pool
SSNOI Property Reconciliations:Seniors Housing OperatingTriple-netOutpatient MedicalTotalSeniors Housing OperatingTriple-netOutpatient MedicalTotal
Consolidated properties
852 568 358 1,778 852 568 358 1,778 
Unconsolidated properties
105 39 79 223 105 39 79 223 
Total properties
957 607 437 2,001 957 607 437 2,001 
Recent acquisitions/development conversions(1)
(88)(13)(41)(142)(102)(13)(45)(160)
Under development
(33)— (7)(40)(32)— (7)(39)
Under redevelopment(2)
(8)(6)(4)(18)(8)(6)(4)(18)
Current held for sale
(31)(40)(2)(73)(31)(40)(2)(73)
Land parcels, loans and subleases
(21)(8)(9)(38)(21)(8)(9)(38)
Transitions(3)
(89)(163)— (252)(89)(163)— (252)
Other(4)
(13)(2)— (15)(13)(2)— (15)
Same store properties
674 375 374 1,423 661 375 370 1,406 
(1) Acquisitions and development conversions will enter the QTD Pool five full quarters and the YTD Pool six full quarters after acquisition or certificate of occupancy.
(2) Redevelopment properties will enter the QTD Pool after five full quarters and the YTD Pool after six full quarters of operations post redevelopment completion.
(3) Transitioned properties will enter the QTD Pool after five full quarters and the YTD Pool after six full quarters of operations with the new operator in place or under the new structure.
(4) Represents properties that are either closed or being closed.









46

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a reconciliation of our consolidated NOI to same store NOI for the periods presented for the respective pools (dollars in thousands):
QTD PoolYTD Pool
Three Months EndedSix Months Ended
SSNOI Reconciliations:June 30, 2023June 30, 2022June 30, 2023June 30, 2022
Seniors Housing Operating:
 
Consolidated NOI
$279,252 $281,911 $532,149 $488,595 
NOI attributable to unconsolidated investments
13,629 11,947 25,756 21,536 
NOI attributable to noncontrolling interests
(15,974)(70,074)(32,235)(91,304)
NOI attributable to non-same store properties
(54,225)(35,269)(114,911)(71,637)
Non-cash NOI attributable to same store properties
(152)(375)(471)(675)
Currency and ownership adjustments (1)
(925)(1,209)(901)(3,051)
SSNOI at Welltower Share221,605 186,931 409,387 343,464 
Triple-net:
Consolidated NOI
291,530 222,869 517,872 446,821 
NOI attributable to unconsolidated investments
6,864 6,788 16,158 12,511 
NOI attributable to noncontrolling interests
(7,723)(10,207)(15,332)(21,313)
NOI attributable to non-same store properties
(165,433)(95,247)(266,591)(191,815)
Non-cash NOI attributable to same store properties
(11,200)(13,999)(25,268)(22,515)
Currency and ownership adjustments (1)
(801)(941)(1,035)(2,733)
SSNOI at Welltower Share113,237 109,263 225,804 220,956 
Outpatient Medical:
Consolidated NOI
127,495 115,674 253,961 229,082 
NOI attributable to unconsolidated investments
4,657 4,910 9,592 9,740 
NOI attributable to noncontrolling interests
(4,708)(5,541)(9,896)(10,781)
NOI attributable to non-same store properties
(10,380)(2,057)(24,481)(6,453)
Non-cash NOI attributable to same store properties
(4,319)(3,788)(8,293)(6,655)
Currency and ownership adjustments (1)
(12)437 167 1,012 
SSNOI at Welltower Share112,733 109,635 221,050 215,945 
SSNOI at Welltower Share:
Seniors Housing Operating221,605 186,931 409,387 343,464 
Triple-net113,237 109,263 225,804 220,956 
Outpatient Medical112,733 109,635 221,050 215,945 
Total$447,575 $405,829 $856,241 $780,365 
(1) Includes adjustments to reflect consistent property ownership percentages, to translate Canadian properties at a USD/CAD rate of 1.37 and to translate U.K. properties at a GBP/USD rate of 1.20.





















47

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The tables below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented (dollars in thousands):
 Three Months Ended
 June 30,March 31,December 31,September 30,June 30,March 31,
EBITDA Reconciliations:202320232022202220222022
Net income (loss)$106,342 $28,635 $1,798 $(2,653)$95,672 $65,751 
Interest expense152,337 144,403 140,391 139,682 127,750 121,696 
Income tax expense (benefit)3,503 3,045 (4,088)3,257 3,065 5,013 
Depreciation and amortization341,945 339,112 342,286 353,699 310,295 304,088 
EBITDA$604,127 $515,195 $480,387 $493,985 $536,782 $496,548 
Interest Coverage Ratio:    
Interest expense$152,337 $144,403 $140,391 $139,682 $127,750 $121,696 
Non-cash interest expense(5,824)(5,083)(4,280)(6,759)(6,606)(4,109)
Capitalized interest11,870 10,335 9,762 8,863 6,387 5,479 
Total interest
158,383 149,655 145,873 141,786 127,531 123,066 
EBITDA$604,127 $515,195 $480,387 $493,985 $536,782 $496,548 
Interest coverage ratio
3.81 x3.44 x3.29 x3.48 x4.21 x4.03 x
Fixed Charge Coverage Ratio:    
Total interest$158,383 $149,655 $145,873 $141,786 $127,531 $123,066 
Secured debt principal payments13,839 14,942 13,989 13,775 14,382 15,968 
Total fixed charges
172,222 164,597 159,862 155,561 141,913 139,034 
EBITDA$604,127 $515,195 $480,387 $493,985 $536,782 $496,548 
Fixed charge coverage ratio
3.51 x3.13 x3.01 x3.18 x3.78 x3.57 x


 Six Months Ended
EBITDA Reconciliations:June 30, 2023June 30, 2022
Net income (loss)$134,977 $161,423 
Interest expense296,740 249,446 
Income tax expense (benefit)6,548 8,078 
Depreciation and amortization681,057 614,383 
EBITDA$1,119,322 $1,033,330 
Interest Coverage Ratio:  
Interest expense$296,740 $249,446 
Non-cash interest expense(10,907)(10,715)
Capitalized interest22,205 11,866 
Total interest308,038 250,597 
EBITDA$1,119,322 $1,033,330 
Interest coverage ratio3.63 x4.12 x
Fixed Charge Coverage Ratio:  
Total interest$308,038 $250,597 
Secured debt principal payments28,781 30,350 
Total fixed charges336,819 280,947 
EBITDA$1,119,322 $1,033,330 
Fixed charge coverage ratio3.32 x3.68 x






48

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.
 Twelve Months Ended
June 30,March 31,December 31,September 30,June 30,March 31,
Adjusted EBITDA Reconciliations:202320232022202220222022
Net income$134,122 $123,452 $160,568 $224,964 $417,953 $368,038 
Interest expense576,813 552,226 529,519 510,976 493,816 488,407 
Income tax expense (benefit)5,717 5,279 7,247 13,386 15,069 9,783 
Depreciation and amortization1,377,042 1,345,392 1,310,368 1,252,583 1,166,638 1,097,228 
EBITDA
2,093,694 2,026,349 2,007,702 2,001,909 2,093,476 1,963,456 
Loss (income) from unconsolidated entities58,751 25,477 21,290 28,814 37,948 38,866 
Stock-based compensation expense32,299 27,709 26,027 22,402 20,766 18,994 
Loss (gain) on extinguishment of debt, net95 697 680 (497)(504)54,505 
Loss (gain) on real estate dispositions, net4,780 6,144 (16,043)(32,139)(151,029)(199,229)
Impairment of assets31,217 30,131 17,502 6,713 3,847 27,539 
Provision for loan losses, net14,192 11,098 10,320 (188)(949)5,083 
Loss (gain) on derivatives and financial instruments, net9,373 5,751 8,334 7,246 (7,737)(6,689)
Other expenses74,249 98,346 101,670 92,199 80,293 56,814 
Lease termination and leasehold interest adjustment (1)
(65,485)(56,397)(64,854)(63,454)(64,094)(7,697)
Casualty losses, net of recoveries15,760 14,865 10,391 7,802 8,472 5,799 
Other impairment (2)
— (620)(620)(620)(620)— 
Adjusted EBITDA$2,268,925 $2,189,550 $2,122,399 $2,070,187 $2,019,869 $1,957,441 
Adjusted Interest Coverage Ratio:    
Interest expense$576,813 $552,226 $529,519 $510,976 $493,816 $488,407 
Capitalized interest40,830 35,347 30,491 26,054 21,860 20,335 
Non-cash interest expense(21,946)(22,728)(21,754)(18,679)(21,258)(18,624)
Total interest
595,697 564,845 538,256 518,351 494,418 490,118 
Adjusted EBITDA$2,268,925 $2,189,550 $2,122,399 $2,070,187 $2,019,869 $1,957,441 
Adjusted interest coverage ratio
3.81 x3.88 x3.94 x3.99 x4.09 x3.99 x
Adjusted Fixed Charge Coverage Ratio:
Total interest$595,697 $564,845 $538,256 $518,351 $494,418 $490,118 
Secured debt principal payments56,545 57,088 58,114 61,002 64,267 65,600 
Total fixed charges
652,242 621,933 596,370 579,353 558,685 555,718 
Adjusted EBITDA$2,268,925 $2,189,550 $2,122,399 $2,070,187 $2,019,869 $1,957,441 
Adjusted fixed charge coverage ratio
3.48 x3.52 x3.56 x3.57 x3.62 x3.52 x
(1) Primarily relates to the derecognition of leasehold interests and the gain recognized in other income.
(2) Represents changes in the reserve for straight-line rent receivable balances relating to leases placed on cash recognition.

Our leverage ratios include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt less cash and cash equivalents and restricted cash), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock. Our leverage ratios are defined as the proportion of net debt to total capitalization.







49

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The table below reflects the reconciliation of our leverage ratios to our balance sheets for the periods presented. Amounts are in thousands, except share price. 
As of
 June 30,March 31,December 31,September 30,June 30,March 31,
 202320232022202220222022
Book capitalization:    
Unsecured credit facility and commercial paper$$$$654,715$354,000$299,968
Long-term debt obligations (1)
16,040,53015,074,32014,661,55214,555,64314,790,43214,352,529
Cash and cash equivalents and restricted cash
(2,299,069)(638,796)(722,292)(425,184)(442,251)(367,043)
Total net debt13,741,46114,435,52413,939,26014,785,17414,702,18114,285,454
Total equity and noncontrolling interests(2)
22,193,11421,596,15521,393,99620,457,65019,873,91319,178,026
Book capitalization$35,934,575$36,031,679$35,333,256$35,242,824$34,576,094$33,463,480
Net debt to book capitalization ratio
38%40%39%42%43%43%
Undepreciated book capitalization:    
Total net debt$13,741,461$14,435,524$13,939,260$14,785,174$14,702,181$14,285,454
Accumulated depreciation and amortization8,599,6228,417,1518,075,7337,687,0777,437,7797,215,622
Total equity and noncontrolling interests(2)
22,193,11421,596,15521,393,99620,457,65019,873,91319,178,026
Undepreciated book capitalization$44,534,197$44,448,830$43,408,989$42,929,901$42,013,873$40,679,102
Net debt to undepreciated book capitalization ratio31%32%32%34%35%35%
Market capitalization:    
Common shares outstanding508,159496,295490,509472,517463,369453,948
Period end share price$80.89$71.69$65.55$64.32$82.35$96.14
Common equity market capitalization$41,104,982$35,579,389$32,152,865$30,392,293$38,158,437$43,642,561
Total net debt13,741,46114,435,52413,939,26014,785,17414,702,18114,285,454
Noncontrolling interests(2)
988,6731,148,0001,099,1821,288,3431,317,7331,282,450
Market capitalization$55,835,116$51,162,913$47,191,307$46,465,810$54,178,351$59,210,465
Net debt to market capitalization ratio
25%28%30%32%27%24%
(1) Amounts include senior unsecured notes, secured debt and lease liabilities related to financing leases, as reflected on our Consolidated Balance Sheets. Operating lease liabilities related to the ASC 842 adoption are excluded.
(2) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests as reflected on our Consolidated Balance Sheets.
Critical Accounting Policies and Estimates
Our unaudited consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions. Management considers an accounting estimate or assumption critical if:
the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and
the impact of the estimates and assumptions on financial condition or operating performance is material.
Management has discussed the development and selection of its critical accounting policies and estimates with the Audit Committee of the Board of Directors. Management believes the current assumptions and other considerations used to estimate amounts reflected in our unaudited consolidated financial statements are appropriate and are not reasonably likely to change in the future. However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition. Please refer to Note 2 to our financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2022 for further information on significant accounting policies that impact us. There have been no material changes to these policies in 2023.
50

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q may contain “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. When Welltower uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “pro forma,” “estimate” or similar expressions that do not relate solely to historical matters, Welltower is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause Welltower’s actual results to differ materially from Welltower’s expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the impact of the COVID-19 pandemic; the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; Welltower’s ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting Welltower’s properties; Welltower’s ability to re-lease space at similar rates as vacancies occur; Welltower’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting Welltower’s properties; changes in rules or practices governing Welltower’s financial reporting; the movement of U.S. and foreign currency exchange rates; Welltower’s ability to maintain its qualification as a REIT; key management personnel recruitment and retention; and other risks described in Welltower’s reports filed from time to time with the SEC. Other important factors are identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, Welltower undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates. We seek to mitigate the underlying foreign currency exposures with gains and losses on derivative contracts hedging these exposures. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates and foreign currency exchange rates.
We historically borrow on our unsecured revolving credit facility and commercial paper program to acquire, construct or make loans relating to health care and seniors housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under our unsecured revolving credit facility and commercial paper program. We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.
A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments after considering the effects of interest rate swaps, whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments’ change in fair value. The following table summarizes the analysis performed as of the dates indicated (in thousands):
51

Item 3. Quantitative and Qualitative Disclosures About Market Risk
 June 30, 2023December 31, 2022
 PrincipalChange inPrincipalChange in
 balancefair valuebalancefair value
Senior unsecured notes$12,296,168 $(515,313)$10,839,782 $(488,159)
Secured debt1,738,697 (59,275)1,448,567 (36,654)
Totals$14,034,865 $(574,588)$12,288,349 $(524,813)
Our variable rate debt, including our unsecured revolving credit facility and commercial paper program, is reflected at fair value. At June 30, 2023, we had $2,156,830,000 outstanding related to our variable rate debt after considering the effects of interest rate swaps. Assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $21,568,000. At December 31, 2022, we had $2,426,134,000 outstanding under our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $24,261,000. 
We are subject to currency fluctuations that may, from time to time, affect our financial condition and results of operations. Increases or decreases in the value of the Canadian Dollar or British Pounds Sterling relative to the U.S. Dollar impact the amount of net income we earn from our investments in Canada and the United Kingdom. Based solely on our results for the three months ended June 30, 2023, including the impact of existing hedging arrangements, if these exchange rates were to increase or decrease by 10%, our annualized net income from these investments would increase or decrease, as applicable, by less than $6,000,000. We will continue to mitigate these underlying foreign currency exposures with non-U.S. denominated borrowings and gains and losses on derivative contracts. If we increase our international presence through investments in, or acquisitions or development of, seniors housing and health care properties outside the U.S., we may also decide to transact additional business or borrow funds in currencies other than U.S. Dollars, Canadian Dollars or British Pounds Sterling. To illustrate the impact of changes in foreign currency markets, we performed a sensitivity analysis on our derivative portfolio whereby we modeled the change in net present values arising from a hypothetical 1% increase in foreign currency exchange rates to determine the instruments’ change in fair value. The following table summarizes the results of the analysis performed (dollars in thousands):
 June 30, 2023December 31, 2022
 CarryingChange inCarryingChange in
 Valuefair valueValuefair value
Foreign currency exchange contracts$97,983 $15,207 $190,418 $14,238 
Debt designated as hedges1,523,381 15,234 1,452,832 14,528 
Totals$1,621,364 $30,441 $1,643,250 $28,766 
For additional information regarding fair values of financial instruments, see “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” and Notes 12 and 17 to our unaudited consolidated financial statements.
Item 4. Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. No changes in our internal control over financial reporting occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

52


PART II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, there are various legal proceedings pending against us that arise in the ordinary course of our business. Management does not believe that the resolution of any of these legal proceedings either individually or in the aggregate will have a material adverse effect on our business, results of operations or financial condition. Further, from time to time, we are party to certain legal proceedings for which third parties, such as tenants, operators and/or managers are contractually obligated to indemnify, defend and hold us harmless. In some of these matters, the indemnitors have insurance for the potential damages. In other matters, we are being defended by tenants and other obligated third parties and these indemnitors may not have sufficient insurance, assets, income or resources to satisfy their defense and indemnification obligations to us. The unfavorable resolution of such legal proceedings could, individually or in the aggregate, materially adversely affect the indemnitors’ ability to satisfy their respective obligations to us, which, in turn, could have a material adverse effect on our business, results of operations or financial condition. It is management’s opinion that there are currently no such legal proceedings pending that will, individually or in the aggregate, have such a material adverse effect. Despite management’s view of the ultimate resolution of these legal proceedings, we may have significant legal expenses and costs associated with the defense of such matters. Further, management cannot predict the outcome of these legal proceedings and if management’s expectation regarding such matters is not correct, such proceedings could have a material adverse effect on our business, results of operations or financial condition.
Item 1A. Risk Factors
There have been no material changes from the risk factors identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the three months ended June 30, 2023, we acquired shares of our common stock held by employees who tendered shares to satisfy tax withholding obligations upon the vesting of previously issued restricted stock awards. Specifically, the number of shares of common stock acquired from employees and the average prices paid per share for each month in the second quarter ended June 30, 2023 are as shown in the table below.
Issuer Purchases of Equity Securities
PeriodTotal Number of Shares PurchasedAverage Price Paid Per ShareTotal Number of Shares Purchased as Part of Publicly Announced Repurchase ProgramMaximum Dollar Value of Shares that May Yet Be Purchased Under the Repurchase Program
April 1, 2023 through April 30, 20231,871 $70.83 — $3,000,000,000 
May 1, 2023 through May 31, 2023225 68.75 — 3,000,000,000 
June 1, 2023 through June 30, 2023— — — 3,000,000,000 
Totals2,096 $70.60 — $3,000,000,000 
On November 7, 2022, our Board of Directors approved a share repurchase program for up to $3,000,000,000 of common stock (the "Stock Repurchase Program"). Under the Stock Repurchase Program, we are not required to purchase shares but may choose to do so in the open market or through privately-negotiated transactions, through block trades, by effecting a tender offer, by way of an accelerated share repurchase program, through the purchase of call options or the sale of put options, or otherwise, or by any combination of the foregoing. We expect to finance any share repurchases using available cash and may use proceeds from borrowings or debt offerings. The Stock Repurchase Program has no expiration date and does not obligate us to repurchase any specific number of shares. We did not repurchase any shares of our common stock through the Stock Repurchase Program during the three months ended June 30, 2023.
Item 5. Other Information 
None.

53


Item 6. Exhibits
4.1
4.2
10.1
10.2
31.1
31.2
32.1
32.2
101.INSXBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema Document
101.CALXBRL Taxonomy Extension Calculation Linkbase Document
101.LABXBRL Taxonomy Extension Label Linkbase Document
101.PREXBRL Taxonomy Extension Presentation Linkbase Document
101.DEFXBRL Taxonomy Extension Definition Linkbase Document
104The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL

















54


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the under signed thereunto duly authorized.

 
WELLTOWER INC.
  
 
Date:August 1, 2023By:  /s/ SHANKH MITRA 
 Shankh Mitra,  
 Chief Executive Officer
 (Principal Executive Officer) 
 
 
   
Date:August 1, 2023By:  /s/ TIMOTHY G. MCHUGH 
 Timothy G. McHugh,  
 Executive Vice President - Chief Financial Officer
 (Principal Financial Officer) 
 
 
   
Date:August 1, 2023By:  /s/ JOSHUA T. FIEWEGER 
 Joshua T. Fieweger,  
 Chief Accounting Officer
 (Principal Accounting Officer) 
 
55